Vitamin D

Last updated

Vitamin D
Drug class
Cholecalciferol2.svg
Class identifiers
Synonyms Calciferols
Use Rickets, osteoporosis, osteomalacia, vitamin D deficiency
ATC code A11CC
Biological target vitamin D receptor
Clinical data
Drugs.com MedFacts Natural Products
External links
MeSH D014807
Legal status
In Wikidata

Vitamin D is a group of fat-soluble secosteroids responsible for increasing intestinal absorption of calcium, magnesium, and phosphate, along with numerous other biological functions. [1] [2] In humans, the most significant compounds within this group are vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol). [2] [3]

Contents

Unlike the other twelve vitamins, vitamin D is only conditionally essential - in a preindustrial society people had adequate exposure to sunlight and the vitamin was a hormone, as the primary natural source of vitamin D was the synthesis of cholecalciferol in the lower layers of the skin’s epidermis, triggered by a photochemical reaction with ultraviolet B (UV-B) radiation from sunlight or UV-B lamps. Cholecalciferol and ergocalciferol can also be obtained through diet and dietary supplements. Foods such as the flesh of fatty fish are good sources of vitamin D, though there are few other foods where it naturally appears in significant amounts. [2] [4] In the U.S. and other countries, cow's milk and plant-based milk substitutes are fortified with vitamin D3, as are many breakfast cereals. Dietary recommendations typically assume that all of a person's vitamin D is taken by mouth, given the paucity of sunlight exposure due to urban living, cultural choices for amount of clothing worn when outdoors, and use of sunscreen because of concerns about safe levels of sunlight exposure, including risk of skin cancer. [2] [5]

Vitamin D obtained from the diet or synthesised in the skin is biologically inactive. It becomes active by two enzymatic hydroxylation steps, the first occurring in the liver and the second in the kidneys. [3] Since most mammals can synthesise sufficient vitamin D with adequate sunlight exposure, it is technically not essential in the diet and thus not a true vitamin. Instead, it functions as a hormone; the activation of the vitamin D pro-hormone produces calcitriol, the active form. Calcitriol then exerts its effects via the vitamin D receptor, a nuclear receptor found in various tissues throughout the body. [6]

Cholecalciferol is converted in the liver to calcifediol (also known as calcidiol or 25-hydroxycholecalciferol), while ergocalciferol is converted to ercalcidiol (25-hydroxyergocalciferol). These two vitamin D metabolites, collectively referred to as 25-hydroxyvitamin D or 25(OH)D, are measured in serum to assess a person's vitamin D status. [7] Calcifediol is further hydroxylated by the kidneys and certain immune cells to form calcitriol (1,25-dihydroxycholecalciferol), the biologically active form of vitamin D. [8] Calcitriol circulates in the blood as a hormone, playing a major role in regulating calcium and phosphate concentrations, as well as promoting bone health and bone remodeling.

The discovery of the vitamin in 1922 was due to effort to identify the dietary deficiency in children with rickets. [9] Present day, government food fortification programs in some countries and recommendations to consume vitamin D supplements are intended to prevent or treat vitamin D deficiency rickets and osteomalacia. There are many other health conditions linked to vitamin D deficiency. However, the evidence for health benefits of vitamin D supplementation in individuals who are already vitamin D sufficient is unproven. [2] [10] [11] [12]

Types

NameChemical compositionStructure
Vitamin D1Mixture of molecular compounds of ergocalciferol with lumisterol, 1:1
Vitamin D2 ergocalciferol (made from ergosterol) Ergocalciferol.svg
Vitamin D3 cholecalciferol

(made from 7-dehydrocholesterol in the skin).

Cholecalciferol.svg
Vitamin D4 22-dihydroergocalciferol 22-Dihydroergocalciferol.svg
Vitamin D5 sitocalciferol

(made from 7-dehydrositosterol)

Vitamin D5 structure.svg

Several forms (vitamers) of vitamin D exist, with the two major forms being vitamin D2 or ergocalciferol, and vitamin D3 or cholecalciferol. [1] The common-use term "vitamin D" refers to both D2 and D3, which were chemically characterized, respectively, in 1931 and 1935. Vitamin D3 was shown to result from the ultraviolet irradiation of 7-dehydrocholesterol. Although a chemical nomenclature for vitamin D forms was recommended in 1981, [13] alternative names remain commonly used. [3]

Chemically, the various forms of vitamin D are secosteroids, meaning that one of the bonds in the steroid rings is broken. [14] The structural difference between vitamin D2 and vitamin D3 lies in the side chain: vitamin D2 has a double bond between carbons 22 and 23, and a methyl group on carbon 24. Vitamin D analogues have also been synthesized. [3]

Biology

The role of active vitamin D or calcitriol (orange) in calcium metabolism in the human body. Calcium regulation.png
The role of active vitamin D or calcitriol (orange) in calcium metabolism in the human body.

The active vitamin D metabolite, calcitriol, exerts its biological effects by binding to the vitamin D receptor (VDR), which is primarily located in the nuclei of target cells. [1] [14] When calcitriol binds to the VDR, it enables the receptor to act as a transcription factor, modulating the gene expression of transport proteins involved in calcium absorption in the intestine, such as TRPV6 and calbindin. [16] The VDR is part of the nuclear receptor superfamily of steroid hormone receptors, which are hormone-dependent regulators of gene expression. These receptors are expressed in cells across most organs.

Activation of VDR in the intestine, bone, kidney, and parathyroid gland cells plays a crucial role in maintaining calcium and phosphorus levels in the blood, a process that is assisted by parathyroid hormone and calcitonin, thereby supporting bone health. [1] [17]

One of the most important functions of vitamin D is to maintain skeletal calcium balance by promoting calcium absorption in the intestines, promoting bone resorption by increasing osteoclast numbers, maintaining calcium and phosphate levels necessary for bone formation, and facilitating the proper function of parathyroid hormone to sustain serum calcium levels. [1] Vitamin D deficiency can lead to decreased bone mineral density, increasing the risk of osteoporosis and bone fractures due to its impact on mineral metabolism. Consequently, vitamin D is also important for bone remodeling, acting as a potent stimulator of bone resorption. [18]

The VDR also regulates cell proliferation and differentiation. Additionally, vitamin D influences the immune system, with VDRs being expressed in several white blood cells, including monocytes and activated T and B cells. [19] In vitro studies indicate that vitamin D increases the expression of the tyrosine hydroxylase gene in adrenal medullary cells and affects the synthesis of neurotrophic factors, nitric oxide synthase, and glutathione, which may control the body's response and adaption to stress. [20] VDR expression decreases with age. [1]

Deficiency

Worldwide, more than one billion people [21] - infants, children, adults and elderly [22] - can be considered vitamin D deficient, with reported percentages dependent on what measurement is used to define "deficient." [23] Deficiency is common in the Middle-East, [22] Asia, [24] Africa [25] and South America, [26] but also exists in North America and Europe [27] [22] [28] [29] Ethnic, dark-skinned immigrant populations in North America, Europe and Australia have a higher percentage of deficiency compared to light-skinned populations that had their origins in Europe. [30] [31] [32]

Serum 25(OH)D concentration is used as a biomarker for vitamin D deficiency. Units of measurement are either ng/mL or nmol/L, with one ng/mL equal to 2.5 nmol/L. There is not a consensus on defining vitamin D deficiency, insufficiency, sufficiency, or optimal for all aspects of health. [23] According to the US Institute of Medicine Dietary Reference Intake Committee, below 30 nmol/L significantly increases the risk of vitamin D deficiency caused rickets in infants and young children, and reduces absorption of dietary calcium from the normal range of 60–80% to as low as 15%, whereas above 40 nmol/L is needed to prevent osteomalacia bone loss in the elderly, and above 50 nmol/L to be sufficient for all health needs. [5] Other sources have defined deficiency as less than 25 nmol/L, insufficiency as 30-50 nmol/L [33] and optimal as greater than 75 nmol/L. [34] [35] Part of the controversy is because studies have reported differences in serum levels of 25(OH)D between ethnic groups, with studies pointing to genetic as well as environmental reasons behind these variations. African-American populations have lower serum 25(OH)D than their age-matched white population, but at all ages have superior calcium absorption efficiency, a higher bone mineral density and as elderly, a lower risk of osteoporosis and fractures. [5] Supplementation in this population to achieve proposed 'standard' concentrations could in theory cause harmful vascular calcification in vitamin-sensitive populations. [36]

Using the 25(OH)D assay as a screening tool of the generally healthy population to identify and treat individuals is considered not as cost-effective as a government mandated fortification program. Instead, there is a recommendation that testing should be limited to those showing symptoms of vitamin D deficiency or who have health conditions known to cause vitamin deficiency. [29]

Causes of insufficient vitamin D synthesis in the skin include insufficient exposure to ultraviolet-B light from sunlight due to living in high latitudes (farther distance from the equator with resultant shorter daylight hours in winter). Serum concentration by the end of winter can be half that at the end of summer. [37] Other causes of insufficient synthesis are sunlight being blocked by air pollution, [38] urban/indoor living, long-term hospitalizations and stays in extended care facilities, cultural or religious lifestyle choices that favors sun-blocking clothing, recommendations to use sun-blocking clothing or sunscreen to reduce risk of skin cancer, and lastly, the UV-B blocking nature of dark skin. [28] Dark-skinned individuals living in temperate climates are more likely to have low vitamin D levels. This is because melanin in the skin, which hinders vitamin D synthesis, makes dark-skinned individuals less efficient at producing vitamin D. [39] In the U.S., vitamin D deficiency is particularly common among Hispanic and African-American populations. [33] Despite the higher incidence of serum concentrations described as deficient, dark-skinned individuals do not necessarily manifest 'deficiency diseases'. [36] [40]

Diets of foods that naturally contain vitamin D are rarely sufficient to maintain recommended serum concentration of 25(OH)D in the absence of the contribution of skin synthesis. Governments have mandated or voluntary food fortification programs to bridge the difference in, respectively, 15 and 10 countries. [41] The United States is one of the few mandated countries. The original fortification practices, circa early 1930s, were limited to cow's milk, which had a large effect on reducing infant and child rickets. In July 2016 the US Food and Drug Administration approved the addition of vitamin D to plant milk beverages intended as milk alternatives, such as beverages made from soy, almond, coconut and oats. [42] At an individual level, people may choose to consume a multi-vitamin/mineral product or else a vitamin-D-only product. [43]

There are many disease states, medical treatments and medications that put people at risk for vitamin D deficiency. Chronic diseases that increase risk include kidney and liver failure, Crohn’s disease, inflammatory bowel disease and malabsorption syndromes such as cystic fibrosis, and hyper- or hypo-parathyroidism. [28] Obesity sequesters vitamin D in fat tissues thereby lowering serum levels, [44] but bariatric surgery to treat obesity interferes with dietary vitamin D absorption, also causing deficiency. [45] Medications include antiretrovirals, anti-seizure drugs, glucocorticoids, systemic antifungals such as ketoconazole, cholestyramine and rifampicin. [28] [46] Organ transplant recipients receive immunosuppressive therapy that is associated with an increased risk to develop skin cancer, so they are advised to avoid sunlight exposure, and to take a vitamin D supplement. [47]

Excess

Vitamin D toxicity, or hypervitaminosis D, is the toxic state of an excess of vitamin D. It is rare, and requires the consumption of vitamin D dietary supplements. [48] There is no general agreement about the intake levels at which vitamin D may cause harm. From a review of the human trial literature, "Doses below 10,000 IU/day are not usually associated with toxicity, whereas doses equal to or above 50,000 IU/day for several weeks or months are frequently associated with toxic side effects including documented hypercalcemia." [5] The normal range for blood concentration of 25-hydroxyvitamin D in adults is 20 to 50 nanograms per milliliter (ng/mL). Blood levels necessary to cause adverse effects in adults are thought to be greater than about 150 ng/mL. [5] An excess of vitamin D causes abnormally hypercalcaemia (high blood concentrations of calcium), which can cause overcalcification of the bones and soft tissues including arteries, heart, and kidneys. Untreated, can lead to irreversible kidney failure. Symptoms of vitamin D toxicity may include the following: increased thirst, increased urination, nausea, vomiting, diarrhea, decreased appetite, irritability, constipation, fatigue, muscle weakness, and insomnia. In almost every case, stopping the vitamin D supplementation combined with a low-calcium diet and corticosteroid drugs will allow for a full recovery within a month. [49] [50] [51] [52]

In 2011, the U.S. National Academy of Medicine revised tolerable upper intake levels (UL) to protect against vitamin D toxicity. Before the revision the UL for ages 9+ years was 50 μg/d (2000 IU/d). [5] Per the revision: "UL is defined as "the highest average daily intake of a nutrient that is likely to pose no risk of adverse health effects for nearly all persons in the general population." [53] The U.S. ULs in microgram (mcg or μg) and International Units (IU) for both males and females, by age, are:

As shown in the Dietary intake section, different government organizations have set different ULs for age groups, but there is accord on the adult maximum of 100 μg/d (4000 IU/d). In contrast, some non-government authors have proposed a safe upper intake level of 250 μg (10,000 IU) per day in healthy adults. [54] [55] In part, this is based on the observation that endogenous skin production with full body exposure to sunlight or use of tanning beds is comparable to taking an oral dose between 250 μg and 625 μg (10,000 IU and 25,000 IU) per day and maintaining blood concentrations on the order of 100 ng/mL. [56] [5]

Although in the U.S. the adult UL is set at 4000 IU/day, over-the-counter products are available at 5000 and 10000 IU. The percentage of the U.S. population taking over 4000 IU/day has increased since 1999. [43]

Special cases

People with primary hyperparathyroidism, are more sensitive to vitamin D supplementation, and as a consequence may develop hypercalcemia. [57] Idiopathic infantile hypercalcemia is caused by a mutation of the CYP24A1 gene, leading to a reduction in the degradation of vitamin D. Infants who have such a mutation have an increased sensitivity to vitamin D and in case of additional intake a risk of hypercalcaemia. [58] The disorder can continue into adulthood. [59]

Health effects

Supplementation with vitamin D is a reliable method for preventing or treating rickets. On the other hand, the effects of vitamin D supplementation on non-skeletal health are uncertain. [60] [61] A review did not find any effect from supplementation on the rates of non-skeletal disease, other than a tentative decrease in mortality in the elderly. [62] Vitamin D supplements do not alter the outcomes for myocardial infarction, stroke or cerebrovascular disease, cancer, bone fractures or knee osteoarthritis. [11] [63]

A US Institute of Medicine (IOM) report states: "Outcomes related to cancer, cardiovascular disease and hypertension, and diabetes and metabolic syndrome, falls and physical performance, immune functioning and autoimmune disorders, infections, neuropsychological functioning, and preeclampsia could not be linked reliably with intake of either calcium or vitamin D, and were often conflicting." [5] :5 Some researchers claim the IOM was too definitive in its recommendations and made a mathematical mistake when calculating the blood level of vitamin D associated with bone health. [64] Members of the IOM panel maintain that they used a "standard procedure for dietary recommendations" and that the report is solidly based on the data. [64]

Mortality, all-causes

Vitamin D3 supplementation has been tentatively found to lead to a reduced risk of death in the elderly, [65] [62] but the effect has not been deemed pronounced, or certain enough, to make taking supplements recommendable. [11] Other forms (vitamin D2, alfacalcidol, and calcitriol) do not appear to have any beneficial effects concerning the risk of death. [65] High blood levels appear to be associated with a lower risk of death, but it is unclear if supplementation can result in this benefit. [66] Both an excess and a deficiency in vitamin D appear to cause abnormal functioning and premature aging. [67] [68] The relationship between serum calcifediol concentrations and all-cause mortality is "U-shaped": mortality is elevated at high and low calcifediol levels, relative to moderate levels. [5] Harm from vitamin D appears to occur at a lower vitamin D level in the dark-skinned Canadian and United States populations which have been studied than in the light-skinned Canadian and United States populations that have been studied. Whether this is so with dark-skinned populations in other parts of the world is unknown. [5] :435

Bone health

Rickets

X-ray of the legs in a two year old child with rickets showing bowing of the femur and low bone density. XrayRicketsLegssmall.jpg
X-ray of the legs in a two year old child with rickets showing bowing of the femur and low bone density.

Rickets, a childhood disease, is characterized by impeded growth and soft, weak, deformed long bones that bend and bow under their weight as children start to walk. Maternal vitamin D deficiency can cause fetal bone defects from before birth and impairment of bone quality after birth. [69] [70] Rickets typically appear between 3 and 18 months of age. [71] This condition can be caused by vitamin D, calcium or phosphorus deficiency. [72] Vitamin D deficiency remains the main cause of rickets among young infants in most countries because breast milk is low in vitamin D, and darker skin, social customs, and climatic conditions can contribute to inadequate sun exposure.[ citation needed ] A post-weaning Western omnivore diet characterized by high intakes of meat, fish, eggs and vitamin D fortified milk is protective, whereas low intakes of those foods and high cereal/grain intake contribute to risk. [17] [73] [74] [75] For young children with rickets, supplementation with vitamin D plus calcium was superior to the vitamin alone for bone healing. [76] [77]

Osteomalacia and osteoporosis

Calcium and Vitamin D3 are often combined, with claims for adult bone health (This label predates current U.S. Food and Drug Administration regulations on health claims. ) RECALLED - Calcium 1200mg plus 1000 IU Vitamin D3 softgels (6711556801).jpg
Calcium and Vitamin D3 are often combined, with claims for adult bone health (This label predates current U.S. Food and Drug Administration regulations on health claims. )

Characteristics of osteomalacia are softening of the bones, leading to bending of the spine, bone fragility, and increased risk for fractures. [1] Osteomalacia is usually present when 25-hydroxyvitamin D levels are less than about 10 ng/mL. [79] Osteomalacia progress to osteoporosis, a condition of reduced bone mineral density with increased bone fragility and risk of bone fractures. Osteoporosis can be a long-term effect of calcium and/or vitamin D insufficiency, the latter contributing by reducing calcium absorption. [2] In the absence of confirmed vitamin D deficiency there is no evidence that vitamin D supplementation without concomitant calcium slows or stops the progression of osteomalacia to osteoporosis. [10] For older people with osteoporosis, taking vitamin D with calcium may help prevent hip fractures, but it also slightly increases the risk of stomach and kidney problems. [80] [81] The reduced rick for fractures is not seen in healthier, community-dwelling elderly. [11] [82] [83] Low serum vitamin D levels have been associated with falls, [84] but taking extra vitamin D does not appear to reduce that risk. [85]

Athletes who are vitamin D deficient are at an increased risk of stress fractures and/or major breaks, particularly those engaging in contact sports. Incremental decreases in risk are observed with rising serum 25(OH)D concentrations plateauing at 50 ng/mL with no additional benefits seen in levels beyond this point. [86]

Cancer

While serum low 25-hydroxyvitamin D status has been associated with a higher risk of cancer in observational studies, [87] [88] [89] the general conclusion is that there is insufficient evidence for an effect of vitamin D supplementation on the risk of cancer, [2] [90] [91] although there is some evidence for reduction in cancer mortality. [87] [92]

Cardiovascular disease

Vitamin D supplementation is not associated with a reduced risk of stroke, cerebrovascular disease, myocardial infarction, or ischemic heart disease. [11] [93] [94] Supplementation does not lower blood pressure in the general population. [95] [96] [97] One meta-analysis found a small increase in risk of stroke when calcium and vitamin D supplements were taken together. [98]

Immune system

Infectious diseases

In general, vitamin D functions to activate the innate and dampen the adaptive immune systems with antibacterial, antiviral and anti-inflammatory effects. [99] [100] Low serum levels of vitamin D appear to be a risk factor for tuberculosis. [101] However, supplementation trials showed no benefit. [102] [103] Vitamin D supplementation at low doses may slightly decrease the overall risk of acute respiratory tract infections. [104] The benefits were found in children and adolescents, and were not confirmed with higher doses. [104]

Inflammatory bowel disease

Vitamin D deficiency has been linked to the severity of inflammatory bowel disease (IBD). [105] However, whether vitamin D deficiency causes IBD or is a consequence of the disease is not clear. [106] Supplementation leads to improvements in scores for clinical inflammatory bowel disease activity and biochemical markers and [107] [106] less frequent relapse of symptoms in IBD. [106]

COVID-19

As of September 2022 the US National Institutes of Health state there is insufficient evidence to recommend for or against using vitamin D supplementation to prevent or treat COVID-19. [108] The UK National Institute for Health and Care Excellence (NICE) does not recommend to offer a vitamin D supplement to people solely to prevent or treat COVID-19. [109] [110] Both organizations included recommendations to continue the previous established recommendations on vitamin D supplementation for other reasons, such as bone and muscle health, as applicable. Both organizations noted that more people may require supplementation due to lower amounts of sun exposure during the pandemic. [108] [109]

Vitamin D deficiency and insufficiency have been associated with adverse outcomes in COVID-19. [111] [112] [113] [114] [115] [116] A review of supplement trials indicated a lower intensive care unit (ICU) admission rate compared to those without supplementation, but without a change in mortality, [117] but another review considered the evidence for treatment of COVID-19 to be very uncertain. [118] Another meta-analysis stated that the use of high doses of vitamin D in people with COVID-19 is not based on solid evidence although calcifediol supplementation may have a protective effect on ICU admissions. [114]

Other conditions

Chronic obstructive pulmonary disease

Vitamin D supplementation substantially reduced the rate of moderate or severe exacerbations of chronic obstructive pulmonary disease (COPD). [119]

Asthma

Vitamin D supplementation does not help prevent asthma attacks or alleviate symptoms. [120]

Diabetes

A meta-analysis reported that vitamin D supplementation significantly reduced the risk of type 2 diabetes for non-obese people with prediabetes. [121] Another meta-analysis reported that vitamin D supplementation significantly improved glycemic control [homeostatic model assessment-insulin resistance (HOMA-IR)], hemoglobin A1C (HbA1C), and fasting blood glucose (FBG) in individuals with type 2 diabetes. [122] In prospective studies, high versus low levels of vitamin D were respectively associated with a significant decrease in risk of type 2 diabetes, combined type 2 diabetes and prediabetes, and prediabetes. [123] A systematic review included one clinical trial that showed vitamin D supplementation together with insulin maintained levels of fasting C-peptide after 12 months better than insulin alone. [124]

Attention deficit hyperactivity disorder (ADHD)

A meta-analysis of observational studies showed that children with ADHD have lower vitamin D levels and that there was a small association between low vitamin D levels at the time of birth and later development of ADHD. [125] Several small, randomized controlled trials of vitamin D supplementation indicated improved ADHD symptoms such as impulsivity and hyperactivity. [126]

Depression

Clinical trials of vitamin D supplementation for depressive symptoms have generally been of low quality and show no overall effect, although subgroup analysis showed supplementation for participants with clinically significant depressive symptoms or depressive disorder had a moderate effect. [127]

Cognition and dementia

A systematic review of clinical studies found an association between low vitamin D levels with cognitive impairment and a higher risk of developing Alzheimer's disease. However, lower vitamin D concentrations are also associated with poor nutrition and spending less time outdoors. Therefore, alternative explanations for the increase in cognitive impairment exist and hence a direct causal relationship between vitamin D levels and cognition could not be established. [128]

Schizophrenia

People diagnosed with schizophrenia tend to have lower serum vitamin D concentrations compared to those without the condition. This may be a consequence of the disease rather than a cause, due, for example, to low dietary vitamin D and less time spent exposed to sunlight. [129] [130] Results from supplementation trials have been inconclusive. [129]

Sexual dysfunction

Erectile dysfunction can be a consequence of vitamin D deficiency. Mechanisms may include regulation of vascular stiffness, the production of vasodilating nitric oxide, and the regulation of vessel permeability. However, the clinical trial literature does not yet contain sufficient evidence that supplementation treats the problem. Part of the complexity is that vitamin D deficiency is also linked to morbidities that are associated with erectile dysfunction, such as obesity, hypertension, diabetes mellitus, hypercholesterolemia, chronic kidney disease and hypogonadism. [131] [132]

In women, vitamin D receptors are expressed in the superficial layers of the urogenital organs. There is an association between vitamin D deficiency and a decline in sexual functions, including sexual desire, orgasm, and satisfaction in women, with symptom severity correlated with vitamin D serum concentration. The clinical trial literature does not yet contain sufficient evidence that supplementation reverses these dysfunctions or improves other aspects of vaginal or urogenital health. [133]

Pregnancy

Pregnant women often do not take the recommended amount of vitamin D. [134] Low levels of vitamin D in pregnancy are associated with gestational diabetes, pre-eclampsia, and small for gestational age infants. [135] Although taking vitamin D supplements during pregnancy raises blood levels of vitamin D in the mother at term, the full extent of benefits for the mother or baby is unclear. [135] [136] [137]

Obesity

Obesity increases the risk of having low serum vitamin D. Supplementation does not lead to weight loss, but weight loss increases serum vitamin D. The theory is that fatty tissue sequesters vitamin D. [44] Bariatric surgery as a treatment for obesity can lead to vitamin deficiencies. Long-term follow-up reported deficiencies for vitamins D, E, A, K and B12, with D the most common at 36%. [45]

Uterine fibroids

There is evidence that the pathogenesis of uterine fibroids is associated with low serum vitamin D and that supplementation reduces the size of fibroids. [138] [139]

Allowed health claims

Governmental regulatory agencies stipulate for the food and dietary supplement industries certain health claims as allowable as statements on packaging.

Europe: European Food Safety Authority (EFSA)

US: Food and Drug Administration (FDA)

Canada: Health Canada

Japan: Foods with Nutrient Function Claims (FNFC)

Dietary intake

United Kingdom
Age groupIntake (μg/day)Maximum intake (μg/day) [144]
Breast-fed infants 0–12 months8.5 – 1025
Formula-fed infants (<500 mL/d)1025
Children 1 – 10 years1050
Children >10 and adults10100
United States
Age groupRDA (IU/day)(μg/day)
Infants 0–6 months400*10
Infants 6–12 months400*10
1–70 years60015
Adults > 70 years80020
Pregnant/Lactating60015
Age groupTolerable upper intake level (IU/day)(μg/day)
Infants 0–6 months1,00025
Infants 6–12 months1,50037.5
1–3 years2,50062.5
4–8 years3,00075
9+ years4,000100
Pregnant/lactating4,000100 [5]
Canada
Age groupRDA (IU) [145] Tolerable upper intake (IU) [145]
Infants 0–6 months400*1,000
Infants 7–12 months400*1,500
Children 1–3 years6002,500
Children 4–8 years6003,000
Children and adults 9–70 years6004,000
Adults > 70 years8004,000
Pregnancy & lactation6004,000
Australia and New Zealand
Age groupAdequate Intake (μg) [146] Upper Level of Intake (μg) [146]
Infants 0–12 months5*25
Children 1–18 years5*80
Adults 19–50 years5*80
Adults 51–70 years10*80
Adults > 70 years15*80
European Food Safety Authority
Age groupAdequate Intake (μg) [147] Tolerable upper limit (μg) [148]
Infants 0–12 months1025
Children 1–10 years1550
Children 11–17 years15100
Adults15100
Pregnancy & Lactation15100
* Adequate intake, no RDA/RDI yet established

Various government institutions have proposed different recommendations for the amount of daily intake of vitamin D. These vary according to precise definition, age, pregnancy or lactation, and the extent assumptions are made regarding skin synthesis of vitamin D. [2] [5] [146] [144] [145] [147] Conversion: 1 μg (microgram) = 40  IU (international unit). [144]

United Kingdom

The UK National Health Service (NHS) recommends that people at risk of vitamin D deficiency, breast-fed babies, formula-fed babies taking less than 500 ml/day, and children aged 6 months to 4 years, should take daily vitamin D supplements throughout the year to ensure sufficient intake. [144] This includes people with limited skin synthesis of vitamin D, who are not often outdoors, are frail, housebound, living in a care home, or usually wearing clothes that cover up most of the skin, or with dark skin, such as having an African, African-Caribbean or south Asian background. Other people may be able to make adequate vitamin D from sunlight exposure from April to September. The NHS and Public Health England recommend that everyone, including those who are pregnant and breastfeeding, consider taking a daily supplement containing 10 μg (400 IU) of vitamin D during autumn and winter because of inadequate sunlight for vitamin D synthesis. [149]

United States

The dietary reference intake for vitamin D issued in 2010 by the Institute of Medicine (IoM) (renamed National Academy of Medicine in 2015), superseded previous recommendations which were expressed in terms of adequate intake. The recommendations were formed assuming the individual has no skin synthesis of vitamin D because of inadequate sun exposure. The reference intake for vitamin D refers to total intake from food, beverages, and supplements, and assumes that calcium requirements are being met. [5] :5 The tolerable upper intake level (UL) is defined as "the highest average daily intake of a nutrient that is likely to pose no risk of adverse health effects for nearly all persons in the general population." [5] :403 Although ULs are believed to be safe, information on the long-term effects is incomplete and these levels of intake are not recommended for long-term consumption. [5] :403:433

For US food and dietary supplement labeling purposes, the amount in a serving is expressed as a percent of Daily Value (%DV). For vitamin D labeling purposes, 100% of the daily value was 400 IU (10 μg), but in May 2016, it was revised to 800 IU (20 μg) to bring it into agreement with the recommended dietary allowance (RDA). [150] [151] A table of the old and new adult daily values is provided at Reference Daily Intake.

The U.S. Preventive Services Task Force (USPSTF) recommended against the routine use of vitamin D and calcium supplements to prevent falls and fractures in older adults, citing insufficient evidence of their effectiveness. [152] The USPSTF highlighted the potential risks of supplementation without prior evaluation for conditions like vitamin D deficiency or osteoporosis. [153] The panel noted that while these supplements provide little benefit in preventing falls or fractures, they could increase the likelihood of kidney stones. The guidance applies to individuals living independently at home, including postmenopausal women and men aged 60 and older. [154]

Canada

Health Canada published recommended dietary intakes (DRIs) and tolerable upper intake levels (ULs) for vitamin D based on the jointly commissioned and funded Institute of Medicine 2010 report. [5] [145]

Australia and New Zealand

Australia and New Zealand published nutrient reference values including guidelines for dietary vitamin D intake in 2006. [146] About a third of Australians have vitamin D deficiency. [155] [156]

European Union

The European Food Safety Authority (EFSA) in 2016 [147] reviewed the current evidence, finding the relationship between serum 25(OH)D concentration and musculoskeletal health outcomes is widely variable. They considered that average requirements and population reference intake values for vitamin D cannot be derived and that a serum 25(OH)D concentration of 50 nmol/L was a suitable target value. For all people over the age of 1, including women who are pregnant or lactating, they set an adequate intake of 15 μg/day (600 IU). [147]

The EFSA reviewed safe levels of intake in 2012, [148] setting the tolerable upper limit for adults at 100 μg/day (4000 IU), a similar conclusion as the IOM.

The Swedish National Food Agency recommends a daily intake of 10 μg (400 IU) of vitamin D3 for children and adults up to 75 years, and 20 μg (800 IU) for adults 75 and older. [157]

Non-government organisations in Europe have made their own recommendations. The German Society for Nutrition recommends 20 μg. [158] The European Menopause and Andropause Society recommends postmenopausal women consume 15 μg (600 IU) until age 70, and 20 μg (800 IU) from age 71. This dose should be increased to 100 μg (4,000 IU) in some patients with very low vitamin D status or in case of co-morbid conditions. [159]

Food sources

In general, vitamin D3 is found in animal source foods, particularly fish, meat, offal, egg, and dairy. [160] Vitamin D2 is found in fungi and is produced by ultraviolet irradiation of ergosterol. [161] The vitamin D2 content in mushrooms increases with exposure to ultraviolet light, [162] and is stimulated by industrial ultraviolet lamps for fortification. [161] The United States Department of Agriculture reports D2 and D3 content combined in one value.

Animal sources
Source [163] IU/g
Cooked egg yolk0.7
Beef liver, cooked, braised0.5
Fish liver oils, such as cod liver oil 100
Fatty fish species
Salmon, pink, cooked, dry heat5.2
Mackerel, Pacific and jack, mixed species, cooked, dry heat4.6
Tuna, canned in oil2.7
Sardines, canned in oil, drained1.9
Fungal sources
Source μg/gIU/g
Agaricus bisporus (common mushroom): D2 + D3
PortobelloRaw0.0030.1
Exposed to ultraviolet light0.114.46
CriminiRaw0.0010.03
Exposed to ultraviolet light0.3212.8

Vitamin D content in typical foods is reduced variably by cooking. Boiled, fried and baked foods retained 6989% of original vitamin D. [164]

Fortification

In the early 1930s, the United States and countries in northern Europe began to fortify milk with vitamin D in an effort to eradicate rickets. This, plus medical advice to expose infants to sunlight, effectively ended the high prevalence of rickets. The proven health benefit of vitamin D led to fortification to many foods, even foods as inappropriate as hot dogs and beer. In the 1950s, due to some highly publicized cases of hypercalcemia and birth defects, vitamin D fortification became regulated, and in some countries discontinued. [37] As of 2024, governments have established mandated or voluntary food fortification programs to combat deficiency in, respectively, 15 and 10 countries. [41] Depending on the country, [41] manufactured foods fortified with either vitamin D2 or D3 may include dairy milk and other dairy foods, fruit juices and fruit juice drinks, meal replacement food bars, soy protein-based beverages, wheat flour or corn meal products, infant formulas, breakfast cereals and 'plant milks', [42] [165] [27] the last described as beverages made from soy, almond, rice, oats and other plant sources intended as alternatives to dairy milk. [166]

Biosynthesis

Synthesis of vitamin D in nature is dependent on the presence of UV radiation and subsequent activation in the liver and in the kidneys. Many animals synthesize vitamin D3 from 7-dehydrocholesterol, and many fungi synthesize vitamin D2 from ergosterol. [161] [167]

Interactive pathway

Click on View at bottom to open.

Click on genes, proteins and metabolites below to link to respective articles. [§ 1]

[[File:
VitaminDSynthesis WP1531.png Go to articleGo to articleGo to articleGo to articlego to articleGo to articleGo to articleGo to articlego to articlego to articlego to articlego to articleGo to articleGo to articlego to articleGo to articlego to articlego to articlego to articleGo to articlego to article
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
VitaminDSynthesis WP1531.png Go to articleGo to articleGo to articleGo to articlego to articleGo to articleGo to articleGo to articlego to articlego to articlego to articlego to articleGo to articleGo to articlego to articleGo to articlego to articlego to articlego to articleGo to articlego to article
|alt=Vitamin D Synthesis Pathway (view / edit)]]
Vitamin D Synthesis Pathway (view / edit)
  1. The interactive pathway map can be edited at WikiPathways: "VitaminDSynthesis_WP1531".

Photochemistry

The photochemistry of vitamin D biosynthesis in animal and fungi Vitamin D biosynthesis in fungi and animals.svg
The photochemistry of vitamin D biosynthesis in animal and fungi
Thermal isomerization of previtamin D3 to vitamin D3 Calcitriol-Biosynthese 2.svg
Thermal isomerization of previtamin D3 to vitamin D3

The transformation in the skin that converts 7-dehydrocholesterol to vitamin D3 occurs in two steps. First, 7-dehydrocholesterol is photolyzed by ultraviolet light in a 6-electron conrotatory ring-opening electrocyclic reaction; the product is previtamin D3. Second, previtamin D3 spontaneously isomerizes to vitamin D3 (cholecalciferol) in an antarafacial sigmatropic [1,7] hydride shift. [168] [169]

The conversion from ergosterol to vitamin D2 follows a similar procedure, forming previtamin D2 by photolysis, which isomerizes to vitamin D2 (ergocalciferol). [170] The transformation of previtamin D2 to vitamin D2 in methanol has a rate comparable to that of previtamin D3. The process is faster in white button mushrooms. [161] :fig. 3

Synthesis in the skin

In the epidermal strata of the skin, vitamin D production is greatest in the stratum basale (colored red in the illustration) and stratum spinosum (colored light brown). Skinlayers.png
In the epidermal strata of the skin, vitamin D production is greatest in the stratum basale (colored red in the illustration) and stratum spinosum (colored light brown).

The skin consists of two primary layers: the inner layer called the dermis, and the outer, thinner epidermis. Vitamin D is produced in the keratinocytes of two innermost strata of the epidermis, the stratum basale and stratum spinosum, which also are able to produce calcitriol and express the vitamin D receptor. [171] Vitamin D3 is produced photochemically from 7-dehydrocholesterol in the skin of most vertebrate animals, including humans. [172] The precursor of vitamin D3, 7-dehydrocholesterol is produced in relatively large quantities. 7-Dehydrocholesterol reacts with UVB light at wavelengths of 290–315 nm. [173] These wavelengths are present in sunlight, as well as in the light emitted by the UV lamps in tanning beds (which produce ultraviolet primarily in the UVA spectrum, but typically produce 4% to 10% of the total UV emissions as UVB. Exposure to light through windows is insufficient because glass almost completely blocks UVB light. [174]

For people with low skin melanin, and hence pale skin tone, adequate amounts of vitamin D can be produced with moderate sun exposure to the face, arms and legs averaging 5–30 minutes twice per week, or approximately 25% of the time that would cause minimal sunburn. The darker the skin on the Fitzpatrick scale or the weaker the sunlight, the more minutes of exposure are needed. [175] Vitamin D overdose from UV exposure is impossible: the skin reaches an equilibrium where the vitamin D degrades as fast as it is created. [50]

Evolution

For at least 1.2 billion years, eukaryotes - a classification of life forms that includes single-cell species, fungi, plants and animals, but not bacteria - have been able to synthesize 7-dehydrocholesterol. When this molecule is exposed to ultraviolet-B (UV-B) light from the sun it absorbs the energy in the process of being conveted to vitamin D. The function was to prevent DNA damage, the vitamin molecule at this time being an end product without function. Present day, phytoplankton in the ocean photosynthesize vitamin D without any calcium management function. Ditto some species of algae, lichen, fungi and plants. [176] [177] [178] Only circa 500 million years ago, when animals began to leave the oceans for land, did the vitamin molecule take on an hormone function as a promoter of calcium regulation. This function required development of a nuclear vitamin D receptor (VDR) that binds the biologically active vitamin D metabolite 1α,25-dihydroxyvitamin (D3), plasma transport proteins and vitamin D metabolizing CYP450 enzymes regulated by calciotropic hormones. The triumvarate of receptor protein, transport and metabolizing enzymes are found only in vertebrates. [179] [180] [181]

The initial function evolved for control of metabolic genes supporting innate and adaptive immunity. Only later did the VDR system start to functions as an important regulator of calcium supply for a calcified skeleton in land-based vertebrates. From amphibians onward, bone management is biodynamic, with bone functioning as internal calcium reservoir under the control of osteoclasts via the combined action of parathyroid hormone and 1α,25-dihydroxyvitamin D3 Thus, the vitamin D story started as inert molecule but gained an essential role for calcium and bone homeostasis in terrestrial animals to cope with the challenge of higher gravity and calcium-poor environment. [179] [180] [181]

Most herbivores produce vitamin D in response to sunlight. Llamas and alpacas out of their natural high altitude intense solar radiation environments are susceptible to vitamin D deficiency at low altitudes. [182] Interestingly, domestic dogs and cats are practically incapable of vitamin D synthesis due to high activity of 7-dehydrocholesterol reductase, which converts any 7-dehydrocholesterol in the skin to cholesterol before it can be UV-B light modified, but instead get vitamin D from diet. [183]

Human evolution

During the long period between one and three million years ago, hominids, including ancestors of homo sapiens, underwent several evolutionary changes. A long-term climate shift toward drier conditions promoted life-changes from sedentary forest-dwelling with a primarily plant-based diet toward upright walking/running on open terrain and more meat consumption. [184] One consequence of the shift to a culture that included more physically active hunting was a need for evaporative cooling from sweat, which to be functional, meant an evolutionary shift toward less body hair, as evaporation from sweat-wet hair would have cooled the hair but not the skin underneath. [185] A second consequence was darker skin. [184] The early humans who evolved in the regions of the globe near the equator had permanent large quantities of the skin pigment melanin in their skins, resulting in brown/black skin tones. For people with light skin tone, exposure to UV radiation induces synthesis of melanin causing the skin to darken, i.e., sun tanning. Either way, the pigment is able to provide protection by dissipating up to 99.9% of absorbed UV radiation. [186] In this way, melanin protects skin cells from UVA and UVB radiation damage that causes photoaging and the risk of malignant melanoma, a cancer of melanin cells. [187] Melanin also protects against photodegradation of the vitamin folate in skin tissue, and in the eyes, preserves eye health. [184]

The dark-skinned humans who had evolved in Africa populated the rest of the world through migration some 50,000 to 80,000 years ago. [188] Following settlement in Asia and Europe, the selective pressure for radiation protective skin tone decreased while a need for efficient vitamin D synthesis in skin increased, resulting in low-melanin, lighter skin tones in the rest of the prehistoric world. [181] [180] [184] However, cultural changes such as clothing, indoor living and working, UV-blocking skin products to reduce the risk of sunburn and emigration of dark-skinned people to countries far from the equator have all contributed to an increased incidence of vitamin D insufficiency and deficiency that need to be addressed by food fortification and vitamin D dietary supplements. [184]

Industrial synthesis

Vitamin D3 (cholecalciferol) is produced industrially by exposing 7-dehydrocholesterol to UVB and UVC light, followed by purification. The 7-dehydrocholesterol is sourced as an extraction from lanolin, a waxy skin secretion in sheep's wool. [189] Vitamin D2 (ergocalciferol) is produced in a similar way using ergosterol from yeast as a starting material. [189] [190]

Mechanism of action

Metabolic activation

Liver hydroxylation of cholecalciferol to calcifediol Cholecalciferol to calcidiol CH3.svg
Liver hydroxylation of cholecalciferol to calcifediol
Kidney hydroxylation of calcifediol to calcitriol Calcidiol to calcitriol CH3.svg
Kidney hydroxylation of calcifediol to calcitriol

Vitamin D is carried via the blood to the liver, where it is converted into the prohormone calcifediol. Circulating calcifediol may then be converted into calcitriol the biologically active form of vitamin D in the kidneys. [191]

Whether synthesized in the skin or ingested, vitamin D is hydroxylated in the liver at position 25 (upper right of the molecule) to form 25-hydroxycholecalciferol (calcifediol or 25(OH)D). [3] This reaction is catalyzed by the microsomal enzyme vitamin D 25-hydroxylase, the product of the CYP2R1 human gene, and expressed by hepatocytes. [192] Once made, the product is released into the plasma, where it is bound to an α-globulin carrier protein named the vitamin D-binding protein. [193]

Calcifediol is transported to the proximal tubules of the kidneys, where it is hydroxylated at the 1-α position (lower right of the molecule) to form calcitriol (1,25-dihydroxycholecalciferol, 1,25(OH)2D). [1] The conversion of calcifediol to calcitriol is catalyzed by the enzyme 25-hydroxyvitamin D3 1-alpha-hydroxylase, which is the product of the CYP27B1 human gene. [1] The activity of CYP27B1 is increased by parathyroid hormone, and also by low calcium or phosphate. [1] Following the final converting step in the kidney, calcitriol is released into the circulation. By binding to vitamin D-binding protein, calcitriol is transported throughout the body, including to the intestine, kidneys, and bones. [14] Calcitriol is the most potent natural ligand of the vitamin D receptor, which mediates most of the physiological actions of vitamin D. [1] [191] In addition to the kidneys, calcitriol is also synthesized by certain other cells, including monocyte-macrophages in the immune system. When synthesized by monocyte-macrophages, calcitriol acts locally as a cytokine, modulating body defenses against microbial invaders by stimulating the innate immune system. [191]

Inactivation

The activity of calcifediol and calcitriol can be reduced by hydroxylation at position 24 by vitamin D3 24-hydroxylase, forming secalciferol and calcitetrol, respectively. [3]

Difference between substrates

Vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) share a similar mechanism of action as outlined above. [3] Metabolites produced by vitamin D2 are named with an er- or ergo- prefix to differentiate them from the D3-based counterparts (sometimes with a chole- prefix). [13]

It is disputed whether these differences lead to a measurable drop in efficacy (see § Food fortification).

Intracellular mechanisms

Calcitriol enters the target cell and binds to the vitamin D receptor in the cytoplasm. This activated receptor enters the nucleus and binds to vitamin D response elements (VDRE) which are specific DNA sequences on genes. [1] Transcription of these genes is stimulated and produces greater levels of the proteins that mediate the effects of vitamin D. [3]

Some reactions of the cell to calcitriol appear to be too fast for the classical VDRE transcription pathway, leading to the discovery of various non-genomic actions of vitamin D. The membrane-bound PDIA3 likely serves as an alternate receptor in this pathway. [196] The classical VDR may still play a role. [197]

History

Children being given cod liver oil, Cambridgeshire, England, 1944 A Modern Village School- Education in Cambridgeshire, England, UK, 1944 D23618.jpg
Children being given cod liver oil, Cambridgeshire, England, 1944
Scott's Emulsion of Pure Cod Liver Oil Trade Card Scott's Emulsion of Pure Cod Liver Oil Trade Card 1994.ARC.0112.jpg
Scott’s Emulsion of Pure Cod Liver Oil Trade Card

In northern European countries, cod liver oil had a long history of folklore medical uses, including applied to the skin and taken orally as a treatment for rheumatism and gout. [198] [199] There were several extraction processes. Fresh livers cut to pieces and suspended on screens over pans of boiling water would drip oil that could be skimmed off the water, yielding a pale oil with a mild fish odor and flavor. For industrial purposes such as a lubricant, cod livers were placed in barrels to rot, with the oil skimmed off over months. The resulting oil was light to dark brown, and exceedingly foul smelling and tasting. In the 1800s, cod liver oil became popular as bottled medicinal products for oral consumption - a teaspoon a day - with both pale and brown oils were used. [198] The trigger for the surge in oral use was the observation made in several European countries in the 1820s that young children fed cod liver oil did not develop rickets. [199] Thus, the concept that a food could prevent a disease predated by 100 years the identification of a substance in the food that was responsible. [199] In northen Europe and the United States, the practice of giving children cod liver oil to prevent rickets persisted well in the 1950s. [198] This overlapped with the fortification of cow's milk with vitamin D, which began in the early 1930s. [37]

Vitamin D was identified and named in 1922. [200] In 1914, American researchers Elmer McCollum and Marguerite Davis had discovered a substance in cod liver oil which later was named "vitamin A". [9] Edward Mellanby, a British researcher, observed that dogs that were fed cod liver oil did not develop rickets, and (wrongly) concluded that vitamin A could prevent the disease. In 1922, McCollum tested modified cod liver oil in which the vitamin A had been destroyed. The modified oil cured the sick dogs, so McCollum concluded the factor in cod liver oil which cured rickets was distinct from vitamin A. He called it vitamin D because it was the fourth vitamin to be named. [9] [201] [202]

In 1925, it was established that when 7-dehydrocholesterol is irradiated with light, a form of a fat-soluble substance is produced, now known as vitamin D3. [9] Adolf Windaus, at the University of Göttingen in Germany, received the Nobel Prize in Chemistry in 1928 "...for the services rendered through his research into the constitution of the sterols and their connection with the vitamins.” [203] Alfred Fabian Hess, his research associate, stated: "Light equals vitamin D." [204] In 1932, Otto Rosenheim and Harold King published a paper putting forward structures for sterols and bile acids, [205] and soon thereafter collaborated with Kenneth Callow and others on isolation and characterization of vitamin D. [206] Windaus further clarified the chemical structure of vitamin D. [207]

In 1969, a specific binding protein for vitamin D called the vitamin D receptor was identified. [208] Shortly thereafter, the conversion of vitamin D to calcifediol and then to calcitriol, the biologically active form, was confirmed. [8] The photosynthesis of vitamin D3 in skin via previtamin D3 and its subsequent metabolism was described in 1980. [209]

Related Research Articles

<span class="mw-page-title-main">Rickets</span> Childhood bone disorder

Rickets, scientific nomenclature: rachitis, is a condition that results in weak or soft bones in children and is caused by either dietary deficiency or genetic causes. Symptoms include bowed legs, stunted growth, bone pain, large forehead, and trouble sleeping. Complications may include bone deformities, bone pseudofractures and fractures, muscle spasms, or an abnormally curved spine. The analogous condition in adults is osteomalacia.

<span class="mw-page-title-main">Vitamin K</span> Fat-soluble vitamers

Vitamin K is a family of structurally similar, fat-soluble vitamers found in foods and marketed as dietary supplements. The human body requires vitamin K for post-synthesis modification of certain proteins that are required for blood coagulation or for controlling binding of calcium in bones and other tissues. The complete synthesis involves final modification of these so-called "Gla proteins" by the enzyme gamma-glutamyl carboxylase that uses vitamin K as a cofactor.

Tocopherols are a class of organic compounds comprising various methylated phenols, many of which have vitamin E activity. Because the vitamin activity was first identified in 1936 from a dietary fertility factor in rats, it was named tocopherol, from Greek τόκοςtókos 'birth' and φέρεινphérein 'to bear or carry', that is 'to carry a pregnancy', with the ending -ol signifying its status as a chemical alcohol.

<span class="mw-page-title-main">Vitamin A</span> Essential nutrient

Vitamin A is a fat-soluble vitamin that is an essential nutrient. The term "vitamin A" encompasses a group of chemically related organic compounds that includes retinol, retinyl esters, and several provitamin (precursor) carotenoids, most notably β-carotene (beta-carotene). Vitamin A has multiple functions: growth during embryo development, maintaining the immune system, and healthy vision. For aiding vision specifically, it combines with the protein opsin to form rhodopsin, the light-absorbing molecule necessary for both low-light and color vision.

<span class="mw-page-title-main">Folate</span> Vitamin B9; nutrient essential for DNA synthesis

Folate, also known as vitamin B9 and folacin, is one of the B vitamins. Manufactured folic acid, which is converted into folate by the body, is used as a dietary supplement and in food fortification as it is more stable during processing and storage. Folate is required for the body to make DNA and RNA and metabolise amino acids necessary for cell division and maturation of blood cells. As the human body cannot make folate, it is required in the diet, making it an essential nutrient. It occurs naturally in many foods. The recommended adult daily intake of folate in the U.S. is 400 micrograms from foods or dietary supplements.

<span class="mw-page-title-main">Dietary supplement</span> Product providing additional nutrients

A dietary supplement is a manufactured product intended to supplement a person's diet by taking a pill, capsule, tablet, powder, or liquid. A supplement can provide nutrients either extracted from food sources, or that are synthetic. The classes of nutrient compounds in supplements include vitamins, minerals, fiber, fatty acids, and amino acids. Dietary supplements can also contain substances that have not been confirmed as being essential to life, and so are not nutrients per se, but are marketed as having a beneficial biological effect, such as plant pigments or polyphenols. Animals can also be a source of supplement ingredients, such as collagen from chickens or fish for example. These are also sold individually and in combination, and may be combined with nutrient ingredients. The European Commission has also established harmonized rules to help insure that food supplements are safe and appropriately labeled.

<span class="mw-page-title-main">Cholecalciferol</span> Vitamin D3, a chemical compound

Cholecalciferol, also known as vitamin D3 or colecalciferol, is a type of vitamin D that is produced by the skin when exposed to UVB light; it is found in certain foods and can be taken as a dietary supplement.

<span class="mw-page-title-main">Ergocalciferol</span> Vitamin D2, a chemical compound

Ergocalciferol, also known as vitamin D2 and nonspecifically calciferol, is a type of vitamin D found in food. It is used as a dietary supplement to prevent and treat vitamin D deficiency due to poor absorption by the intestines or liver disease. It may also be used for low blood calcium due to hypoparathyroidism. It is taken by mouth or via injection into a muscle.

<span class="mw-page-title-main">Osteomalacia</span> Softening of bones due to impaired bone metabolism

Osteomalacia is a disease characterized by the softening of the bones caused by impaired bone metabolism primarily due to inadequate levels of available phosphate, calcium, and vitamin D, or because of resorption of calcium. The impairment of bone metabolism causes inadequate bone mineralization.

β-Carotene Red-orange pigment of the terpenoids class

β-Carotene (beta-carotene) is an organic, strongly colored red-orange pigment abundant in fungi, plants, and fruits. It is a member of the carotenes, which are terpenoids (isoprenoids), synthesized biochemically from eight isoprene units and thus having 40 carbons.

<span class="mw-page-title-main">Vegetarian nutrition</span> Nutritional and human health aspects of vegetarian diets

Vegetarian nutrition is the set of health-related challenges and advantages of vegetarian diets.

<span class="mw-page-title-main">Calcitriol</span> Active form of vitamin D

Calcitriol is a hormone and the active form of vitamin D, normally made in the kidney. It is also known as 1,25-dihydroxycholecalciferol. It binds to and activates the vitamin D receptor in the nucleus of the cell, which then increases the expression of many genes. Calcitriol increases blood calcium mainly by increasing the uptake of calcium from the intestines.

<span class="mw-page-title-main">Vitamin D toxicity</span> Human disease

Vitamin D toxicity, or hypervitaminosis D, is the toxic state of an excess of vitamin D. The normal range for blood concentration of 25-hydroxyvitamin D in adults is 20 to 50 nanograms per milliliter (ng/mL). Blood levels necessary to cause adverse effects in adults are thought to be greater than about 150 ng/mL, leading the Endocrine Society to suggest an upper limit for safety of 100 ng/mL.

<span class="mw-page-title-main">Nutrition and pregnancy</span> Nutrient intake and dietary planning undertaken before, during and after pregnancy

Nutrition and pregnancy refers to the nutrient intake, and dietary planning that is undertaken before, during and after pregnancy. Nutrition of the fetus begins at conception. For this reason, the nutrition of the mother is important from before conception as well as throughout pregnancy and breastfeeding. An ever-increasing number of studies have shown that the nutrition of the mother will have an effect on the child, up to and including the risk for cancer, cardiovascular disease, hypertension and diabetes throughout life.

<span class="mw-page-title-main">Calcifediol</span> Chemical compound

Calcifediol, also known as calcidiol, 25-hydroxycholecalciferol, or 25-hydroxyvitamin D3 (abbreviated 25(OH)D3), is a form of vitamin D produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme vitamin D 25-hydroxylase. Calcifediol can be further hydroxylated by the enzyme 25(OH)D-1α-hydroxylase, primarily in the kidney, to form calcitriol (1,25-(OH)2D3), which is the active hormonal form of vitamin D.

<span class="mw-page-title-main">Vitamin D deficiency</span> Human disorder

Vitamin D deficiency or hypovitaminosis D is a vitamin D level that is below normal. It most commonly occurs in people when they have inadequate exposure to sunlight, particularly sunlight with adequate ultraviolet B rays (UVB). Vitamin D deficiency can also be caused by inadequate nutritional intake of vitamin D; disorders that limit vitamin D absorption; and disorders that impair the conversion of vitamin D to active metabolites, including certain liver, kidney, and hereditary disorders. Deficiency impairs bone mineralization, leading to bone-softening diseases, such as rickets in children. It can also worsen osteomalacia and osteoporosis in adults, increasing the risk of bone fractures. Muscle weakness is also a common symptom of vitamin D deficiency, further increasing the risk of fall and bone fractures in adults. Vitamin D deficiency is associated with the development of schizophrenia.

<span class="mw-page-title-main">Michael F. Holick</span> American physician–scientist

Michael F. Holick is an American adult endocrinologist, specializing in vitamin D, such as the identification of both calcidiol, the major circulating form of vitamin D, and calcitriol, the active form of vitamin D. His work has been the basis for diagnostic tests and therapies for vitamin D-related diseases. He is a professor of medicine at the Boston University Medical Center and editor-in-chief of the journal Clinical Laboratory.

<span class="mw-page-title-main">Vegan nutrition</span> Nutritional and human health aspects of vegan diets

Vegan nutrition refers to the nutritional and human health aspects of vegan diets. A well-planned vegan diet is suitable to meet all recommendations for nutrients in every stage of human life. Vegan diets tend to be higher in dietary fiber, magnesium, folic acid, vitamin C, vitamin E, and phytochemicals; and lower in calories, saturated fat, iron, cholesterol, long-chain omega-3 fatty acids, vitamin D, calcium, zinc, and vitamin B12.

Associations have been shown between vitamin D levels and several respiratory tract infections suggesting that vitamin D deficiency may predispose to infection. Outbreaks of respiratory infections occur predominantly during months associated with lower exposure to the sun. While Institute of Medicine concluded in a 2011 report that the existing data were "not consistently supportive of a causal role" for vitamin D in reducing the risk of infection, other reviews suggest that vitamin D supplementation can provide a protective role in reducing the incidence or severity of respiratory infections.

Vitamin D deficiency in Australia has been estimated as aflicting nearly one-quarter of all adults.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 "Vitamin D". Micronutrient Information Center, Linus Pauling Institute, Oregon State University, Corvallis. 11 February 2021. Archived from the original on 8 April 2015. Retrieved 14 March 2022.
  2. 1 2 3 4 5 6 7 8 "Vitamin D: Fact Sheet for Health Professionals". Office of Dietary Supplements, US National Institutes of Health. 12 August 2022. Archived from the original on 9 April 2021. Retrieved 22 February 2022.
  3. 1 2 3 4 5 6 7 8 9 10 11 Bikle DD (March 2014). "Vitamin D metabolism, mechanism of action, and clinical applications". Chemistry & Biology. 21 (3): 319–29. doi:10.1016/j.chembiol.2013.12.016. PMC   3968073 . PMID   24529992.
  4. Lehmann U, Gjessing HR, Hirche F, Mueller-Belecke A, Gudbrandsen OA, Ueland PM, et al. (October 2015). "Efficacy of fish intake on vitamin D status: a meta-analysis of randomized controlled trials". The American Journal of Clinical Nutrition. 102 (4): 837–47. doi: 10.3945/ajcn.114.105395 . PMID   26354531.
  5. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Institute of Medicine (2011). Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds.). Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press. doi:10.17226/13050. ISBN   978-0-309-16394-1. PMID   21796828. S2CID   58721779. Archived from the original on 26 January 2021. Retrieved 17 September 2017.
  6. Norman AW (August 2008). "From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health". The American Journal of Clinical Nutrition. 88 (2): 491S–9S. doi: 10.1093/ajcn/88.2.491S . PMID   18689389.
  7. Hollis BW (January 1996). "Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it". Calcified Tissue International. 58 (1): 4–5. doi:10.1007/BF02509538. PMID   8825231. S2CID   35887181.
  8. 1 2 Norman AW, Myrtle JF, Midgett RJ, Nowicki HG, Williams V, Popják G (July 1971). "1,25-dihydroxycholecalciferol: identification of the proposed active form of vitamin D3 in the intestine". Science. 173 (3991): 51–4. Bibcode:1971Sci...173...51N. doi:10.1126/science.173.3991.51. PMID   4325863. S2CID   35236666.
  9. 1 2 3 4 Wolf G (June 2004). "The discovery of vitamin D: the contribution of Adolf Windaus". The Journal of Nutrition. 134 (6): 1299–302. doi: 10.1093/jn/134.6.1299 . PMID   15173387.
  10. 1 2 Reid IR, Bolland MJ, Grey A (January 2014). "Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis". Lancet. 383 (9912): 146–55. doi:10.1016/s0140-6736(13)61647-5. PMID   24119980. S2CID   37968189.
  11. 1 2 3 4 5 Bolland MJ, Grey A, Gamble GD, Reid IR (April 2014). "The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis". The Lancet. Diabetes & Endocrinology (Meta-analysis). 2 (4): 307–20. doi:10.1016/S2213-8587(13)70212-2. PMID   24703049.
  12. "The Lancet Diabetes & Endocrinology: Vitamin D supplementation in adults does not prevent fractures, falls or improve bone mineral density". EurekAlert!. Archived from the original on 24 March 2022. Retrieved 23 February 2022. The authors conclude that there is therefore little reason to use vitamin D supplements to maintain or improve musculoskeletal health, except for the prevention of rare conditions such as rickets and osteomalacia in high risk groups, which can be caused by vitamin D deficiency after long lack of exposure to sunshine.
  13. 1 2 "IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN): Nomenclature of vitamin D. Recommendations 1981". European Journal of Biochemistry. 124 (2): 223–7. May 1982. doi: 10.1111/j.1432-1033.1982.tb06581.x . PMID   7094913.
  14. 1 2 3 Fleet JC, Shapses SA (2020). "Vitamin D". In BP Marriott, DF Birt, VA Stallings, AA Yates (eds.). Present Knowledge in Nutrition, Eleventh Edition. London, United Kingdom: Academic Press (Elsevier). pp. 93–114. ISBN   978-0-323-66162-1.
  15. Boron WF, Boulpaep EL (29 March 2016). Medical Physiology E-Book. Elsevier Health Sciences. ISBN   978-1-4557-3328-6. Archived from the original on 19 March 2023. Retrieved 9 April 2017.
  16. Bouillon R, Van Cromphaut S, Carmeliet G (February 2003). "Intestinal calcium absorption: Molecular vitamin D mediated mechanisms". Journal of Cellular Biochemistry. 88 (2): 332–9. doi:10.1002/jcb.10360. PMID   12520535. S2CID   9853381.
  17. 1 2 Holick MF (December 2004). "Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease". The American Journal of Clinical Nutrition. 80 (6 Suppl): 1678S–88S. doi: 10.1093/ajcn/80.6.1678S . PMID   15585788.
  18. Bell TD, Demay MB, Burnett-Bowie SA (September 2010). "The biology and pathology of vitamin D control in bone". Journal of Cellular Biochemistry. 111 (1): 7–13. doi:10.1002/jcb.22661. PMC   4020510 . PMID   20506379.
  19. Watkins RR, Lemonovich TL, Salata RA (May 2015). "An update on the association of vitamin D deficiency with common infectious diseases". Canadian Journal of Physiology and Pharmacology. 93 (5): 363–8. doi:10.1139/cjpp-2014-0352. PMID   25741906.
  20. Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK (February 1996). "Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells". Brain Research. Molecular Brain Research. 36 (1): 193–6. doi:10.1016/0169-328X(95)00314-I. PMID   9011759.
  21. Holick MF, Chen TC (April 2008). "Vitamin D deficiency: a worldwide problem with health consequences". Am J Clin Nutr. 87 (4): 1080S–6S. doi:10.1093/ajcn/87.4.1080S. PMID   18400738.
  22. 1 2 3 Palacios C, Gonzalez L (October 2014). "Is vitamin D deficiency a major global public health problem?". J Steroid Biochem Mol Biol. 144 Pt A: 138–45. doi:10.1016/j.jsbmb.2013.11.003. PMC   4018438 . PMID   24239505.
  23. 1 2 Tello M (16 April 2020). "Vitamin D: What's the "right" level?". Harvard Health Publishing. Retrieved 15 December 2024.
  24. Jiang Z, Pu R, Li N, Chen C, Li J, Dai W, et al. (2023). "High prevalence of vitamin D deficiency in Asia: A systematic review and meta-analysis". Crit Rev Food Sci Nutr. 63 (19): 3602–11. doi:10.1080/10408398.2021.1990850. PMID   34783278.{{cite journal}}: CS1 maint: overridden setting (link)
  25. Mogire RM, Mutua A, Kimita W, Kamau A, Bejon P, Pettifor JM, et al. (January 2020). "Prevalence of vitamin D deficiency in Africa: a systematic review and meta-analysis". Lancet Glob Health. 8 (1): e134–42. doi:10.1016/S2214-109X(19)30457-7. PMC   7024961 . PMID   31786117.
  26. Mendes MM, Gomes AP, Araújo MM, Coelho AS, Carvalho KM, Botelho PB (September 2023). "Prevalence of vitamin D deficiency in South America: a systematic review and meta-analysis". Nutr Rev. 81 (10): 1290–309. doi:10.1093/nutrit/nuad010. PMID   36882047.
  27. 1 2 Spiro A, Buttriss JL (December 2014). "Vitamin D: An overview of vitamin D status and intake in Europe". Nutrition Bulletin. 39 (4): 322–350. doi:10.1111/nbu.12108. PMC   4288313 . PMID   25635171.
  28. 1 2 3 4 Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Tmava Berisha A, et al. (November 2020). "Vitamin D deficiency 2.0: an update on the current status worldwide". Eur J Clin Nutr. 74 (11): 1498–513. doi:10.1038/s41430-020-0558-y. PMC   7091696 . PMID   31959942.
  29. 1 2 Harvey NC, Ward KA, Agnusdei D, Binkley N, Biver E, Campusano C, et al. (August 2024). "Optimisation of vitamin D status in global populations". Osteoporos Int. 35 (8): 1313–22. doi:10.1007/s00198-024-07127-z. PMID   38836946.{{cite journal}}: CS1 maint: overridden setting (link)
  30. Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, et al. (April 2016). "Vitamin D deficiency in Europe: pandemic?". The American Journal of Clinical Nutrition. 103 (4): 1033–44. doi:10.3945/ajcn.115.120873. PMC   5527850 . PMID   26864360.{{cite journal}}: CS1 maint: overridden setting (link)
  31. Martin CA, Gowda U, Renzaho AM (January 2016). "The prevalence of vitamin D deficiency among dark-skinned populations according to their stage of migration and region of birth: A meta-analysis". Nutrition. 32 (1): 21–32. doi:10.1016/j.nut.2015.07.007. PMID   26643747.
  32. Lowe NM, Bhojani I (June 2017). "Special considerations for vitamin D in the south Asian population in the UK". Therapeutic Advances in Musculoskeletal Disease. 9 (6): 137–44. doi:10.1177/1759720X17704430. PMC   5466148 . PMID   28620422.
  33. 1 2 Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. (July 2011). "Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline". The Journal of Clinical Endocrinology and Metabolism. 96 (7): 1911–30. doi: 10.1210/jc.2011-0385 . PMID   21646368.
  34. Bischoff-Ferrari HA (2008). "Optimal Serum 25-Hydroxyvitamin D Levels for Multiple Health Outcomes". Sunlight, Vitamin D and Skin Cancer (Review). Advances in Experimental Medicine and Biology. Vol. 810. Springer. pp. 500–25. doi:10.1007/978-0-387-77574-6_5. ISBN   978-0-387-77573-9. PMID   25207384.
  35. Dahlquist DT, Dieter BP, Koehle MS (2015). "Plausible ergogenic effects of vitamin D on athletic performance and recovery". Journal of the International Society of Sports Nutrition (Review). 12: 33. doi: 10.1186/s12970-015-0093-8 . PMC   4539891 . PMID   26288575.
  36. 1 2 Freedman BI, Register TC (June 2012). "Effect of race and genetics on vitamin D metabolism, bone and vascular health". Nature Reviews. Nephrology. 8 (8): 459–66. doi:10.1038/nrneph.2012.112. PMC   10032380 . PMID   22688752. S2CID   29026212.
  37. 1 2 3 Wacker M, Holick MF (January 2013). "Sunlight and Vitamin D: A global perspective for health". Dermatoendocrinol. 5 (1): 51–108. doi:10.4161/derm.24494. PMC   3897598 . PMID   24494042.
  38. Hoseinzadeh E, Taha P, Wei C, Godini H, Ashraf GM, Taghavi M, et al. (March 2018). "The impact of air pollutants, UV exposure and geographic location on vitamin D deficiency". Food Chem Toxicol. 113: 241–54. doi:10.1016/j.fct.2018.01.052. PMID   29409825.
  39. Khalid AT, Moore CG, Hall C, Olabopo F, Rozario NL, Holick MF, et al. (September 2017). "Utility of sun-reactive skin typing and melanin index for discerning vitamin D deficiency". Pediatric Research. 82 (3): 444–51. doi:10.1038/pr.2017.114. PMC   5570640 . PMID   28467404.
  40. O'Connor MY, Thoreson CK, Ramsey NL, Ricks M, Sumner AE (2013). "The uncertain significance of low vitamin D levels in African descent populations: a review of the bone and cardiometabolic literature". Progress in Cardiovascular Diseases. 56 (3): 261–9. doi:10.1016/j.pcad.2013.10.015. PMC   3894250 . PMID   24267433.
  41. 1 2 3 "Map: Count of Nutrients In Fortification Standards". Global Fortification Data Exchange. 2024. Retrieved 16 December 2024.
  42. 1 2 "Vitamin D for Milk and Milk Alternatives". Food and Drug Administration (FDA). 15 July 2016. Archived from the original on 22 December 2020. Retrieved 22 February 2017.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  43. 1 2 Rooney MR, Harnack L, Michos ED, Ogilvie RP, Sempos CT, Lutsey PL (June 2017). "Trends in Use of High-Dose Vitamin D Supplements Exceeding 1000 or 4000 International Units Daily, 1999–2014". JAMA. 317 (23): 2448–50. doi:10.1001/jama.2017.4392. PMC   5587346 . PMID   28632857.
  44. 1 2 Mallard SR, Howe AS, Houghton LA (October 2016). "Vitamin D status and weight loss: a systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials". Am J Clin Nutr. 104 (4): 1151–59. doi:10.3945/ajcn.116.136879. PMID   27604772.
  45. 1 2 Chen L, Chen Y, Yu X, Liang S, Guan Y, Yang J, et al. (July 2024). "Long-term prevalence of vitamin deficiencies after bariatric surgery: a meta-analysis". Langenbecks Arch Surg. 409 (1): 226. doi:10.1007/s00423-024-03422-9. PMID   39030449.
  46. Giustina A, Bilezikian JP, Adler RA, Banfi G, Bikle DD, Binkley NC, et al. (September 2024). "Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows". Endocr Rev. 45 (5): 625–54. doi:10.1210/endrev/bnae009. PMC   11405507 . PMID   38676447.{{cite journal}}: CS1 maint: overridden setting (link)
  47. Saternus R, Vogt T, Reichrath J (2020). "Update: Solar UV Radiation, Vitamin D, and Skin Cancer Surveillance in Organ Transplant Recipients (OTRs)". Sunlight, Vitamin D and Skin Cancer. Adv Exp Med Biol. Vol. 1268. pp. 335–53. doi:10.1007/978-3-030-46227-7_17. ISBN   978-3-030-46226-0. PMID   32918227.
  48. Dudenkov DV, Yawn BP, Oberhelman SS, Fischer PR, Singh RJ, Cha SS, et al. (May 2015). "Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study". Mayo Clin Proc. 90 (5): 577–86. doi:10.1016/j.mayocp.2015.02.012. PMC   4437692 . PMID   25939935.
  49. Vitamin D at The Merck Manual of Diagnosis and Therapy Professional Edition
  50. 1 2 Holick MF (July 2007). "Vitamin D deficiency". The New England Journal of Medicine. 357 (3): 266–81. doi:10.1056/NEJMra070553. PMID   17634462. S2CID   18566028.
  51. Brown JE, Isaacs J, Krinke B, Lechtenberg E, Murtaugh M (28 June 2013). Nutrition Through the Life Cycle. Cengage Learning. ISBN   978-1-285-82025-5. Archived from the original on 19 March 2023. Retrieved 9 April 2017.
  52. Insel P, Ross D, Bernstein M, McMahon K (18 March 2015). Discovering Nutrition. Jones & Bartlett Publishers. ISBN   978-1-284-06465-0. Archived from the original on 19 March 2023. Retrieved 9 April 2017.
  53. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. (January 2011). "The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know". The Journal of Clinical Endocrinology and Metabolism. 96 (1): 53–8. doi:10.1210/jc.2010-2704. PMC   3046611 . PMID   21118827.{{cite journal}}: CS1 maint: overridden setting (link)
  54. Hathcock JN, Shao A, Vieth R, Heaney R (January 2007). "Risk assessment for vitamin D". The American Journal of Clinical Nutrition. 85 (1): 6–18. doi: 10.1093/ajcn/85.1.6 . PMID   17209171.
  55. Vieth R (December 2007). "Vitamin D toxicity, policy, and science". Journal of Bone and Mineral Research. 22 (Suppl 2): V64-8. doi: 10.1359/jbmr.07s221 . PMID   18290725. S2CID   24460808.
  56. Holick MF (March 1995). "Environmental factors that influence the cutaneous production of vitamin D". The American Journal of Clinical Nutrition. 61 (3 Suppl): 638S–645S. doi: 10.1093/ajcn/61.3.638S . PMID   7879731.
  57. Vieth R (May 1999). "Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety" (PDF). The American Journal of Clinical Nutrition. 69 (5): 842–56. doi:10.1093/ajcn/69.5.842. PMID   10232622.
  58. De Paolis E, Scaglione GL, De Bonis M, Minucci A, Capoluongo E (October 2019). "CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype". Clinical Chemistry and Laboratory Medicine. 57 (11): 1650–67. doi: 10.1515/cclm-2018-1208 . PMID   31188746.
  59. Tebben PJ, Singh RJ, Kumar R (October 2016). "Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment". Endocrine Reviews. 37 (5): 521–47. doi:10.1210/er.2016-1070. PMC   5045493 . PMID   27588937.
  60. Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, et al. (August 2009). "Vitamin D and calcium: a systematic review of health outcomes". Evidence Report/Technology Assessment (183): 1–420. PMC   4781105 . PMID   20629479.
  61. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP (April 2014). "Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials". BMJ. 348: g2035. doi:10.1136/bmj.g2035. PMC   3972415 . PMID   24690624.
  62. 1 2 Autier P, Boniol M, Pizot C, Mullie P (January 2014). "Vitamin D status and ill health: a systematic review". The Lancet. Diabetes & Endocrinology. 2 (1): 76–89. doi:10.1016/S2213-8587(13)70165-7. PMID   24622671.
  63. Hussain S, Singh A, Akhtar M, Najmi AK (September 2017). "Vitamin D supplementation for the management of knee osteoarthritis: a systematic review of randomized controlled trials". Rheumatology International. 37 (9): 1489–98. doi:10.1007/s00296-017-3719-0. PMID   28421358. S2CID   23994681.
  64. 1 2 Maxmen A (July 2011). "Nutrition advice: the vitamin D-lemma" (PDF). Nature. 475 (7354): 23–5. doi: 10.1038/475023a . PMID   21734684. Archived (PDF) from the original on 3 August 2020. Retrieved 17 November 2011.
  65. 1 2 Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. (January 2014). "Vitamin D supplementation for prevention of mortality in adults". The Cochrane Database of Systematic Reviews (Systematic review). 1 (1): CD007470. doi:10.1002/14651858.CD007470.pub3. PMC   11285307 . PMID   24414552.
  66. Schöttker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot L, et al. (Consortium on Health Ageing: Network of Cohorts in Europe the United States) (June 2014). "Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States". BMJ. 348 (jun17 16): g3656. doi:10.1136/bmj.g3656. PMC   4061380 . PMID   24938302.
  67. Tuohimaa P (March 2009). "Vitamin D and aging". The Journal of Steroid Biochemistry and Molecular Biology. 114 (1–2): 78–84. doi:10.1016/j.jsbmb.2008.12.020. PMID   19444937. S2CID   40625040.
  68. Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A (December 2009). "Vitamin D, nervous system and aging". Psychoneuroendocrinology. 34 (Suppl 1): S278–86. doi:10.1016/j.psyneuen.2009.07.003. PMID   19660871. S2CID   17462970.
  69. Elidrissy AT (September 2016). "The Return of Congenital Rickets, Are We Missing Occult Cases?". Calcified Tissue International (Review). 99 (3): 227–36. doi:10.1007/s00223-016-0146-2. PMID   27245342. S2CID   14727399.
  70. Paterson CR, Ayoub D (October 2015). "Congenital rickets due to vitamin D deficiency in the mothers". Clinical Nutrition (Review). 34 (5): 793–8. doi:10.1016/j.clnu.2014.12.006. PMID   25552383.
  71. Wagner CL, Greer FR (November 2008). "Prevention of rickets and vitamin D deficiency in infants, children, and adolescents". Pediatrics. 122 (5): 1142–52. doi:10.1542/peds.2008-1862. PMID   18977996. S2CID   342161.
  72. Lerch C, Meissner T (October 2007). Lerch C (ed.). "Interventions for the prevention of nutritional rickets in term born children". The Cochrane Database of Systematic Reviews. 2010 (4): CD006164. doi:10.1002/14651858.CD006164.pub2. PMC   8990776 . PMID   17943890.
  73. Clements MR (1989). "The problem of rickets in UK Asians". Journal of Human Nutrition and Dietetics. 2 (2): 105–16. doi:10.1111/j.1365-277X.1989.tb00015.x.
  74. Pettifor JM (December 2004). "Nutritional rickets: deficiency of vitamin D, calcium, or both?". The American Journal of Clinical Nutrition. 80 (6 Suppl): 1725S–9S. doi: 10.1093/ajcn/80.6.1725S . PMID   15585795.
  75. Dupuis EM (1 February 2002). Nature's Perfect Food: How Milk Became America's Drink. NYU Press. ISBN   978-0-8147-1938-1. Archived from the original on 19 March 2023. Retrieved 9 April 2017.
  76. Chibuzor MT, Graham-Kalio D, Osaji JO, Meremikwu MM, et al. (Cochrane Metabolic and Endocrine Disorders Group) (April 2020). "Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in children". The Cochrane Database of Systematic Reviews. 2020 (4): CD012581. doi:10.1002/14651858.CD012581.pub2. PMC   7164979 . PMID   32303107.
  77. Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, et al. (February 2016). "Global Consensus Recommendations on Prevention and Management of Nutritional Rickets". The Journal of Clinical Endocrinology and Metabolism. 101 (2): 394–415. doi:10.1210/jc.2015-2175. PMC   4880117 . PMID   26745253.{{cite journal}}: CS1 maint: overridden setting (link)
  78. 1 2 "Guidance for Industry: Food Labeling Guide". Food and Drug Administration (FDA). January 2013. Archived from the original on 22 December 2020. Retrieved 17 July 2019.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  79. Holick MF (March 2006). "High prevalence of vitamin D inadequacy and implications for health". Mayo Clinic Proceedings. 81 (3): 353–73. doi: 10.4065/81.3.353 . PMID   16529140.
  80. Avenell A, Mak JC, O'Connell D (April 2014). "Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men". The Cochrane Database of Systematic Reviews. 4 (4): CD000227. doi:10.1002/14651858.CD000227.pub4. PMC   7032685 . PMID   24729336.
  81. Bischoff-Ferrari HA, Willett WC, Orav EJ, Oray EJ, Lips P, Meunier PJ, et al. (July 2012). "A pooled analysis of vitamin D dose requirements for fracture prevention" (PDF). The New England Journal of Medicine. 367 (1): 40–9. doi:10.1056/NEJMoa1109617. hdl:1871/48765. PMID   22762317. S2CID   24338997. Archived (PDF) from the original on 15 December 2020. Retrieved 17 July 2019.
  82. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA (December 2011). "Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force". Annals of Internal Medicine. 155 (12): 827–38. doi:10.7326/0003-4819-155-12-201112200-00005. PMID   22184690. S2CID   22380502.
  83. Zhao JG, Zeng XT, Wang J, Liu L (December 2017). "Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis". JAMA. 318 (24): 2466–2482. doi:10.1001/jama.2017.19344. PMC   5820727 . PMID   29279934.
  84. Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, et al. (August 2007). "Effectiveness and safety of vitamin D in relation to bone health". Evidence Report/Technology Assessment (158): 1–235. PMC   4781354 . PMID   18088161.
  85. Bolland MJ, Grey A, Gamble GD, Reid IR (July 2014). "Vitamin D supplementation and falls: a trial sequential meta-analysis". The Lancet. Diabetes & Endocrinology. 2 (7): 573–80. doi:10.1016/S2213-8587(14)70068-3. PMID   24768505.
  86. Shuler FD, Wingate MK, Moore GH, Giangarra C (November 2012). "Sports health benefits of vitamin D". Sports Health. 4 (6): 496–501. doi:10.1177/1941738112461621. PMC   3497950 . PMID   24179588.
  87. 1 2 Sluyter JD, Manson JE, Scragg R (January 2021). "Vitamin D and Clinical Cancer Outcomes: A Review of Meta-Analyses". JBMR Plus. 5 (1): e10420. doi:10.1002/jbm4.10420. PMC   7839823 . PMID   33553987.
  88. Zhao Y, Chen C, Pan W, Gao M, He W, Mao R, et al. (May 2016). "Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: A systematic review and network meta-analysis". Nutrition. 32 (5): 515–23. doi:10.1016/j.nut.2015.10.023. PMID   26822497.
  89. Hernández-Alonso P, Boughanem H, Canudas S, Becerra-Tomás N, Fernández de la Puente M, Babio N, et al. (July 2021). "Circulating vitamin D levels and colorectal cancer risk: A meta-analysis and systematic review of case-control and prospective cohort studies". Critical Reviews in Food Science and Nutrition. 63 (1): 1–17. doi:10.1080/10408398.2021.1939649. hdl: 10609/136992 . PMID   34224246. S2CID   235746547.
  90. "Vitamin D and cancer prevention". National Cancer Institute, US National Institutes of Health. 21 October 2013. Archived from the original on 13 February 2015. Retrieved 15 December 2016.
  91. Goulão, Beatriz, Stewart, Fiona, Ford, John A., MacLennan, Graeme, Avenell, Alison (2018). "Cancer and vitamin D supplementation: a systematic review and meta-analysis". The American Journal of Clinical Nutrition. 107 (4): 652–63. doi: 10.1093/ajcn/nqx047 . PMID   29635490.
  92. Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E (May 2019). "Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials". Annals of Oncology. 30 (5): 733–743. doi:10.1093/annonc/mdz059. PMC   6821324 . PMID   30796437.
  93. Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Dhillon H, Swaid B, et al. (August 2019). "Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis". JAMA Cardiology. 4 (8): 765–76. doi:10.1001/jamacardio.2019.1870. PMC   6584896 . PMID   31215980.
  94. Nudy M, Krakowski G, Ghahramani M, Ruzieh M, Foy AJ (2020). "Vitamin D supplementation, cardiac events and stroke: A systematic review and meta-regression analysis". Int J Cardiol Heart Vasc. 28: 100537. doi:10.1016/j.ijcha.2020.100537. PMC   7240168 . PMID   32462077.
  95. Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, et al. (May 2015). "Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data". JAMA Internal Medicine. 175 (5): 745–54. doi:10.1001/jamainternmed.2015.0237. PMC   5966296 . PMID   25775274.
  96. Zhang D, Cheng C, Wang Y, Sun H, Yu S, Xue Y, et al. (2020). "Effect of Vitamin D on Blood Pressure and Hypertension in the General Population: An Update Meta-Analysis of Cohort Studies and Randomized Controlled Trials". Prev Chronic Dis. 17: E03. doi:10.5888/pcd17.190307. PMC   6977781 . PMID   31922371.
  97. Abboud M, Al Anouti F, Papandreou D (2021). "Vitamin D status and blood pressure in children and adolescents: a systematic review of observational studies". Systematic Reviews. 10 (1): 60. doi: 10.1186/s13643-021-01584-x . PMC   7898425 . PMID   33618764.
  98. Khan SU, Khan MU, Riaz H, Valavoor S, Zhao D, Vaughan L, et al. (August 2019). "Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map". Annals of Internal Medicine. 171 (3): 190–98. doi:10.7326/m19-0341. PMC   7261374 . PMID   31284304.
  99. Hewison M (2011). "Vitamin D and innate and adaptive immunity". Vitamins and the Immune System. Vitamins & Hormones. Vol. 86. Academic Press. pp. 23–62. doi:10.1016/B978-0-12-386960-9.00002-2. ISBN   978-0-12-386960-9. PMID   21419266.
  100. Bishop E, Ismailova A, Dimeloe SK, Hewison M, White JH (August 2020). "Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory". JBMR Plus. 5 (1): e10405. doi:10.1002/jbm4.10405. PMC   7461279 . PMID   32904944.
  101. Nnoaham KE, Clarke A (February 2008). "Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis". International Journal of Epidemiology. 37 (1): 113–9. CiteSeerX   10.1.1.513.3969 . doi:10.1093/ije/dym247. PMID   18245055.
  102. Goyal JP, Singh S, Bishnoi R, Bhardwaj P, Kaur RJ, Dhingra S, et al. (July 2022). "Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis". Expert Rev Anti Infect Ther. 20 (7): 1049–59. doi:10.1080/14787210.2022.2071702. PMID   35477334.
  103. Cao Y, Wang X, Liu P, Su Y, Yu H, Du J (January 2022). "Vitamin D and the risk of latent tuberculosis infection: a systematic review and meta-analysis". BMC Pulm Med. 22 (1): 39. doi: 10.1186/s12890-022-01830-5 . PMC   8772077 . PMID   35045861.
  104. 1 2 "SACN rapid review: Vitamin D and acute respiratory tract infections". Public Health England. Archived from the original on 14 January 2021. Retrieved 6 January 2021.
  105. Del Pinto R, Pietropaoli D, Chandar AK, Ferri C, Cominelli F (November 2015). "Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis". Inflammatory Bowel Diseases. 21 (11): 2708–17. doi:10.1097/MIB.0000000000000546. PMC   4615394 . PMID   26348447.
  106. 1 2 3 Wallace C, Gordon M, Sinopoulou V, Limketkai BN, et al. (Cochrane Gut Group) (October 2023). "Vitamin D for the treatment of inflammatory bowel disease". The Cochrane Database of Systematic Reviews. 2023 (10): CD011806. doi:10.1002/14651858.CD011806.pub2. PMC   10542962 . PMID   37781953.
  107. Guzman-Prado Y, Samson O, Segal JP, Limdi JK, Hayee B (May 2020). "Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis". Inflammatory Bowel Diseases. 26 (12): 1819–30. doi:10.1093/ibd/izaa087. PMID   32385487.
  108. 1 2 "Vitamin D". Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health (NIH). 26 September 2022. Retrieved 4 July 2023.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  109. 1 2 COVID-19 rapid guideline: vitamin D (PDF) (Technical report). National Institute for Health and Care Excellence (NICE). December 2020. ISBN   978-1-4731-3942-8. NG187. Archived from the original on 3 December 2021. Retrieved 22 February 2021.
  110. Evidence reviews for the use of vitamin D supplementation as prevention and treatment of COVID-19 (PDF) (Report). National Institute for Health and Care Excellence (NICE). December 2020. Archived from the original on 20 October 2021. Retrieved 22 February 2021.
  111. Liu N, Sun J, Wang X, Zhang T, Zhao M, Li H (March 2021). "Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis". International Journal of Infectious Diseases. 104: 58–64. doi:10.1016/j.ijid.2020.12.077. PMC   7833186 . PMID   33401034.
  112. Kazemi A, Mohammadi V, Aghababaee SK, Golzarand M, Clark CC, Babajafari S (October 2021). "Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis". Advances in Nutrition. 12 (5): 1636–58. doi: 10.1093/advances/nmab012 . PMC   7989595 . PMID   33751020.
  113. Petrelli F, Luciani A, Perego G, Dognini G, Colombelli PL, Ghidini A (July 2021). "Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies". The Journal of Steroid Biochemistry and Molecular Biology. 211: 105883. doi:10.1016/j.jsbmb.2021.105883. PMC   7997262 . PMID   33775818.
  114. 1 2 Bassatne A, Basbous M, Chakhtoura M, El Zein O, Rahme M, El-Hajj Fuleihan G (June 2021). "The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis". Metabolism (Systematic review). 119: 154753. doi:10.1016/j.metabol.2021.154753. PMC   7989070 . PMID   33774074.
  115. Damascena AD, Azevedo LM, Oliveira TA, Santana JD, Pereira M (August 2021). "Addendum to vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis". Critical Reviews in Food Science and Nutrition. 63 (4): 557–62. doi:10.1080/10408398.2021.1951652. PMID   34384300. S2CID   236997712.
  116. Dissanayake HA, de Silva NL, Sumanatilleke M, de Silva SD, Gamage KK, Dematapitiya C, et al. (April 2022). "Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis". The Journal of Clinical Endocrinology and Metabolism. 107 (5): 1484–502. doi:10.1210/clinem/dgab892. PMC   8689831 . PMID   34894254.
  117. Shah K, Saxena D, Mavalankar D (January 2021). "Vitamin D supplementation, COVID-19 & Disease Severity: A meta-analysis". QJM: Monthly Journal of the Association of Physicians. 114 (3): 175–81. doi:10.1093/qjmed/hcab009. PMC   7928587 . PMID   33486522.
  118. Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, et al. (May 2021). "Vitamin D supplementation for the treatment of COVID-19: a living systematic review". The Cochrane Database of Systematic Reviews. 2021 (5): CD015043. doi:10.1002/14651858.CD015043. PMC   8406457 . PMID   34029377. S2CID   235202971.
  119. Jolliffe DA, Greenberg L, Hooper RL, Mathyssen C, Rafiq R, de Jongh RT, et al. (April 2019). "Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials". Thorax. 74 (4): 337–45. doi: 10.1136/thoraxjnl-2018-212092 . PMID   30630893. S2CID   58548871.
  120. Williamson A, Martineau AR, Sheikh A, Jolliffe D, Griffiths CJ (February 2023). "Vitamin D for the management of asthma". Cochrane Database Syst Rev. 2023 (2): CD011511. doi:10.1002/14651858.CD011511.pub3. PMC   9899558 . PMID   36744416.
  121. Zhang Y, Tan H, Tang J, Li J, Chong W, Hai Y, et al. (July 2020). "Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis". Diabetes Care. 43 (7): 1650–58. doi: 10.2337/dc19-1708 . PMID   33534730. S2CID   219897727.
  122. Sahebi R, Rezayi M, Emadzadeh M, Salehi M, Tayefi M, Parizadeh SM, et al. (February 2019). "The effects of vitamin D supplementation on indices of glycemic control in Iranian diabetics: A systematic review and meta-analysis". Complementary Therapies in Clinical Practice. 34: 294–304. doi:10.1016/j.ctcp.2018.12.009. PMID   30712741. S2CID   57479957.{{cite journal}}: CS1 maint: overridden setting (link)
  123. Mohammadi S, Hajhashemy Z, Saneei P (June 2021). "Serum vitamin D levels in relation to type-2 diabetes and prediabetes in adults: a systematic review and dose-response meta-analysis of epidemiologic studies". Critical Reviews in Food Science and Nutrition. 2 (29): 8178–8198. doi:10.1080/10408398.2021.1926220. PMID   34076544. S2CID   235295924.
  124. Brophy S, Davies H, Mannan S, Brunt H, Williams R (September 2011). "Interventions for latent autoimmune diabetes (LADA) in adults". The Cochrane Database of Systematic Reviews. 2011 (9): CD006165. doi:10.1002/14651858.cd006165.pub3. PMC   6486159 . PMID   21901702.
  125. Khoshbakht Y, Bidaki R, Salehi-Abargouei A (January 2018). "Vitamin D Status and Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Observational Studies". Advances in Nutrition. 9 (1): 9–20. doi: 10.1093/advances/nmx002 . PMC   6333940 . PMID   29438455.
  126. Gan J, Galer P, Ma D, Chen C, Xiong T (November 2019). "The Effect of Vitamin D Supplementation on Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials". Journal of Child and Adolescent Psychopharmacology. 29 (9): 670–87. doi:10.1089/cap.2019.0059. PMID   31368773. S2CID   199054851.
  127. Shaffer JA, Edmondson D, Wasson LT, Falzon L, Homma K, Ezeokoli N, et al. (April 2014). "Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials". Psychosomatic Medicine. 76 (3): 190–6. doi:10.1097/psy.0000000000000044. PMC   4008710 . PMID   24632894.
  128. Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, et al. (September 2012). "Vitamin D, cognition, and dementia: a systematic review and meta-analysis". Neurology. 79 (13): 1397–405. doi:10.1212/WNL.0b013e31826c197f. PMC   3448747 . PMID   23008220.
  129. 1 2 Cui X, McGrath JJ, Burne TH, Eyles DW (July 2021). "Vitamin D and schizophrenia: 20 years on". Mol Psychiatry. 26 (7): 2708–20. doi:10.1038/s41380-021-01025-0. PMC   8505257 . PMID   33500553.
  130. Zhu JL, Luo WW, Cheng X, Li Y, Zhang QZ, Peng WX (June 2020). "Vitamin D deficiency and Schizophrenia in Adults: A Systematic Review and Meta-analysis of Observational Studies". Psychiatry Res. 288: 112959. doi:10.1016/j.psychres.2020.112959. PMID   32335466.
  131. Crafa A, Cannarella R, Barbagallo F, Leanza C, Palazzolo R, Flores HA, et al. (June 2023). "Mechanisms Suggesting a Relationship between Vitamin D and Erectile Dysfunction: An Overview". Biomolecules. 13 (6): 930. doi: 10.3390/biom13060930 . PMC   10295993 . PMID   37371510.
  132. Canguven O, Al Malki AH (January 2021). "Vitamin D and Male Erectile Function: An Updated Review". World J Mens Health. 39 (1): 31–37. doi:10.5534/wjmh.190151. PMC   7752519 . PMID   32009309.
  133. Hassanein MM, Huri HZ, Abduelkarem AR, Baig K (August 2023). "Therapeutic Effects of Vitamin D on Vaginal, Sexual, and Urological Functions in Postmenopausal Women". Nutrients. 15 (17): 3804. doi: 10.3390/nu15173804 . PMC   10490181 . PMID   37686835.
  134. Wagner CL, Taylor SN, Dawodu A, Johnson DD, Hollis BW (March 2012). "Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus". Nutrients. 4 (3): 208–30. doi: 10.3390/nu4030208 . PMC   3347028 . PMID   22666547.
  135. 1 2 Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM (March 2013). "Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies". BMJ. 346: f1169. doi: 10.1136/bmj.f1169 . PMID   23533188.
  136. Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, Papp E (November 2017). "Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials". BMJ. 359: j5237. doi:10.1136/bmj.j5237. PMC   5706533 . PMID   29187358.
  137. Palacios C, Kostiuk LL, Cuthbert A, Weeks J (July 2024). "Vitamin D supplementation for women during pregnancy". The Cochrane Database of Systematic Reviews. 2024 (7): CD008873. doi:10.1002/14651858.CD008873.pub5. PMC  11287789. PMID   39077939.
  138. Alsharif SA, Baradwan S, Alshahrani MS, Khadawardi K, AlSghan R, Badghish E, et al. (2024). "Effect of Oral Consumption of Vitamin D on Uterine Fibroids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials". Nutr Cancer. 76 (3): 226–35. doi:10.1080/01635581.2023.2288716. PMID   38234246.{{cite journal}}: CS1 maint: overridden setting (link)
  139. Combs A, Singh B, Nylander E, Islam MS, Nguyen HV, Parra E, et al. (April 2023). "A Systematic Review of Vitamin D and Fibroids: Pathophysiology, Prevention, and Treatment". Reprod Sci. 30 (4): 1049–64. doi:10.1007/s43032-022-01011-z. PMID   35960442.
  140. 1 2 3 European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010). "Scientific opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13(1) of Regulation (EC) No 1924/2006". EFSA Journal. 8 (2): 1468–85. doi:10.2903/j.efsa.2010.1468.
  141. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011). "Scientific opinion on the substantiation of a health claim related to vitamin D and risk of falling pursuant to Article 14 of Regulation (EC) No 1924/2006" (PDF). EFSA Journal. 9 (9): 2382–2400. doi: 10.2903/j.efsa.2011.2382 . Archived (PDF) from the original on 20 August 2019. Retrieved 20 August 2019.
  142. "Health Canada Scientific Summary on the U. S. Health Claim Regarding Calcium and Osteoporosis". Bureau of Nutritional Sciences Food Directorate, Health Products and Food Branch Health Canada. 1 May 2000. Archived from the original on 3 December 2016. Retrieved 29 January 2012.
  143. Shimizu T (2002). "Newly established regulation in Japan: foods with health claims". Asia Pac J Clin Nutr. 11 (2): S94–6. doi:10.1046/j.1440-6047.2002.00007.x. PMID   12074195.
  144. 1 2 3 4 "Vitamins and minerals – Vitamin D". National Health Service . 3 August 2020. Archived from the original on 30 October 2017. Retrieved 15 November 2020.
  145. 1 2 3 4 "Vitamin D and Calcium: Updated Dietary Reference Intakes". Nutrition and Healthy Eating. Health Canada. 5 December 2008. Archived from the original on 14 June 2017. Retrieved 28 April 2018.
  146. 1 2 3 4 Nutrient Reference Values for Australia and New Zealand Including Recommended Dietary Intakes. Canberra: National Health and Medical Research Council. 2006. ISBN   1-86496-243-7. Archived from the original on 3 March 2023. Retrieved 19 March 2023.
  147. 1 2 3 4 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (29 June 2016). "Dietary reference values for vitamin D". EFSA Journal. 14 (10): e04547. doi: 10.2903/j.efsa.2016.4547 . hdl: 11380/1228918 .
  148. 1 2 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2012). "Scientific Opinion on the Tolerable Upper Intake Level of vitamin D". EFSA Journal (Submitted manuscript). 10 (7): 2813. doi: 10.2903/j.efsa.2012.2813 . hdl: 2434/257871 .
  149. "PHE publishes new advice on vitamin D". Public Health England. 21 July 2016. Archived from the original on 3 January 2021. Retrieved 15 November 2020.
  150. "Federal Register May 27, 2016 Food Labeling: Revision of the Nutrition and Supplement Facts Labels. FR page 33982" (PDF). Archived (PDF) from the original on 8 August 2016. Retrieved 20 August 2019.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  151. "Daily Value Reference of the Dietary Supplement Label Database (DSLD)". Dietary Supplement Label Database (DSLD). Archived from the original on 7 April 2020. Retrieved 16 May 2020.
  152. "Draft Recommendation: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication | United States Preventive Services Taskforce". www.uspreventiveservicestaskforce.org. Retrieved 22 December 2024.
  153. "USPSTF advises against vitamin D supplementation to prevent falls in older adults". www.healio.com. Retrieved 22 December 2024.
  154. Howard J (17 December 2024). "Popular vitamin won't prevent a fall or fracture in older adults, health panel says. But here's what can help". CNN. Retrieved 22 December 2024.
  155. Salleh A (12 June 2012). "Vitamin D food fortification on the table". Australian Broadcasting Corporation. Archived from the original on 22 December 2020. Retrieved 12 June 2012.
  156. "Australian Health Survey: Biomedical Results for Nutrients, 2011–12". Australian Bureau of Statistics. 21 December 2011. Archived from the original on 10 March 2023. Retrieved 19 March 2023.
  157. "Vitamin D (translated)" (in Swedish). Swedish National Food Agency. Archived from the original on 26 October 2020. Retrieved 19 October 2018.
  158. Vitamin-D-Bedarf bei fehlender endogener Synthese Deutsche Gesellschaft für Ernährung, January 2012
  159. Pérez-López FR, Brincat M, Erel CT, Tremollieres F, Gambacciani M, Lambrinoudaki I, et al. (January 2012). "EMAS position statement: Vitamin D and postmenopausal health". Maturitas. 71 (1): 83–8. doi: 10.1016/j.maturitas.2011.11.002 . PMID   22100145.
  160. Schmid A, Walther B (July 2013). "Natural vitamin D content in animal products". Advances in Nutrition. 4 (4): 453–62. doi:10.3945/an.113.003780. PMC   3941824 . PMID   23858093.
  161. 1 2 3 4 Keegan RJ, Lu Z, Bogusz JM, Williams JE, Holick MF (January 2013). "Photobiology of vitamin D in mushrooms and its bioavailability in humans". Dermato-Endocrinology. 5 (1): 165–76. doi:10.4161/derm.23321. PMC   3897585 . PMID   24494050.
  162. Haytowitz DB (2009). "Vitamin D in mushrooms" (PDF). Nutrient Data Laboratory, US Department of Agriculture. Archived (PDF) from the original on 1 February 2021. Retrieved 16 April 2018.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  163. "Search, National Nutrient Database for Standard Reference Release 27". US Department of Agriculture, Agricultural Research Service. 2014. Archived from the original on 19 April 2014. Retrieved 12 June 2015.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  164. Jakobsen J, Knuthsen P (April 2014). "Stability of vitamin D in foodstuffs during cooking". Food Chemistry. 148: 170–5. doi:10.1016/j.foodchem.2013.10.043. PMID   24262542.
  165. de Lourdes Samaniego-Vaesken M, Alonso-Aperte E, Varela-Moreiras G (2012). "Vitamin food fortification today". Food & Nutrition Research. 56: 5459. doi:10.3402/fnr.v56i0.5459. PMC   3319130 . PMID   22481896.
  166. "Alternative to dairy milk". osoblanco. 16 January 2020. Archived from the original on 22 December 2020. Retrieved 20 January 2020.
  167. Holick MF (1992). "Evolutionary biology and pathology of vitamin D". J Nutr Sci Vitaminol (Tokyo). Spec No: 79–83. doi: 10.3177/jnsv.38.special_79 . PMID   1297827.
  168. Holick MF (April 1987). "Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables". Federation Proceedings. 46 (5): 1876–82. PMID   3030826.
  169. Deluca HF (January 2014). "History of the discovery of vitamin D and its active metabolites". BoneKEy Reports. 3: 479. doi:10.1038/bonekey.2013.213. PMC   3899558 . PMID   24466410.
  170. Eyley SC, Williams DH (1975). "Photolytic production of vitamin D. The preparative value of a photo-sensitiser". Journal of the Chemical Society, Chemical Communications (20): 858a. doi:10.1039/C3975000858A.
  171. Bikle DD (March 2010). "Vitamin D and the skin". Journal of Bone and Mineral Metabolism. 28 (2): 117–30. doi:10.1007/s00774-009-0153-8. PMID   20107849. S2CID   6072459.
  172. Crissey SD, Ange KD, Jacobsen KL, Slifka KA, Bowen PE, Stacewicz-Sapuntzakis M, et al. (January 2003). "Serum concentrations of lipids, vitamin d metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos". The Journal of Nutrition. 133 (1): 160–6. doi: 10.1093/jn/133.1.160 . PMID   12514284.
  173. Holick MF (2018). "Chapter 4: Photobiology of Vitamin D". In Feldman D, Pike JW, Bouillon R, Giovannucci E, Goltzman D, Hewison M (eds.). Vitamin D: Volume 1: Biochemistry, Physiology and Diagnostics (4th ed.). London, UK: Academic Press. ISBN   978-0-12-809965-0.
  174. Holick MF (2020). "Sunlight, UV Radiation, Vitamin D, and Skin Cancer: How Much Sunlight do We Need?". Sunlight, Vitamin D and Skin Cancer. Advances in Experimental Medicine and Biology. Vol. 1268. Springer. pp. 19–36. doi:10.1007/978-3-030-46227-7_2. ISBN   978-3-030-46226-0. PMID   32918212. S2CID   221636019. 108 references
  175. Young AR, Morgan KA, Harrison GI, Lawrence KP, Petersen B, Wulf HC, et al. (October 2021). "A revised action spectrum for vitamin D synthesis by suberythemal UV radiation exposure in humans in vivo". Proceedings of the National Academy of Sciences of the United States of America. 118 (40). Bibcode:2021PNAS..11815867Y. doi: 10.1073/pnas.2015867118 . PMC   8501902 . PMID   34580202.
  176. Jäpelt RB, Jakobsen J (May 2013). "Vitamin D in plants: a review of occurrence, analysis, and biosynthesis". Frontiers in Plant Science. 4: 136. doi: 10.3389/fpls.2013.00136 . PMC   3651966 . PMID   23717318.
  177. Göring H (November 2018). "Vitamin D in Nature: A Product of Synthesis and/or Degradation of Cell Membrane Components". Biochemistry. Biokhimiia. 83 (11): 1350–1357. doi:10.1134/S0006297918110056. PMID   30482146. S2CID   53437216.
  178. Björn LO, Wang T (January 2000). "Vitamin D in an ecological context". International Journal of Circumpolar Health. 59 (1): 26–32. PMID   10850004.
  179. 1 2 Bouillon R, Suda T (January 2014). "Vitamin D: calcium and bone homeostasis during evolution". BoneKEy Reports. 3: 480. doi:10.1038/bonekey.2013.214. PMC   3899559 . PMID   24466411.
  180. 1 2 3 Hanel A, Carlberg C (March 2020). "Vitamin D and evolution: Pharmacologic implications". Biochem Pharmacol. 173: 113595. doi:10.1016/j.bcp.2019.07.024. PMID   31377232.
  181. 1 2 3 Carlberg C (July 2022). "Vitamin D in the Context of Evolution". Nutrients. 14 (15): 3018. doi: 10.3390/nu14153018 . PMC   9332464 . PMID   35893872.
  182. Uhl EW (December 2018). "The pathology of vitamin D deficiency in domesticated animals: An evolutionary and comparative overview". Int J Paleopathol. 23: 100–9. doi: 10.1016/j.ijpp.2018.03.001 . PMID   29544996.
  183. Zafalon RV, Risolia LW, Pedrinelli V, Vendramini TH, Rodrigues RB, Amaral AR, et al. (January 2020). "Vitamin D metabolism in dogs and cats and its relation to diseases not associated with bone metabolism". Journal of Animal Physiology and Animal Nutrition. 104 (1): 322–42. doi: 10.1111/jpn.13259 . PMID   31803981.
  184. 1 2 3 4 5 Jarrett P, Scragg R (January 2020). "Evolution, Prehistory and Vitamin D". Int J Environ Res Public Health. 17 (2): 646. doi: 10.3390/ijerph17020646 . PMC   7027011 . PMID   31963858.
  185. Wade N (19 August 2003). "Why Humans and Their Fur Parted Ways". The New York Times. ISSN   0362-4331. Archived from the original on 18 June 2009. Retrieved 24 August 2019.
  186. Meredith P, Riesz J (2004). "Radiative relaxation quantum yields for synthetic eumelanin". Photochemistry and Photobiology. 79 (2): 211–6. arXiv: cond-mat/0312277 . doi:10.1111/j.1751-1097.2004.tb00012.x. PMID   15068035. S2CID   222101966.
  187. Brenner M, Hearing VJ (2008). "The protective role of melanin against UV damage in human skin". Photochemistry and Photobiology. 84 (3): 539–49. doi:10.1111/j.1751-1097.2007.00226.x. PMC   2671032 . PMID   18435612.
  188. "A Single Migration From Africa Populated the World, Studies Find". The New York Times . 22 September 2016. Archived from the original on 2 May 2019. Retrieved 2 March 2017.
  189. 1 2 Holick MF (November 2005). "The vitamin D epidemic and its health consequences" (PDF). The Journal of Nutrition. 135 (11): 2739S–48S. doi: 10.1093/jn/135.11.2739S . PMID   16251641. Archived from the original (PDF) on 18 November 2017. Vitamin D3 is produced commercially by extracting 7-dehydrocholesterol from wool fat, followed by UVB irradiation and purification [...] [Vitamin D2] is commercially made by irradiating and then purifying the ergosterol extracted from yeast
  190. Hirsch AL (12 May 2011). "Chapter 6: Industrial Aspects of Vitamin D". In Feldman D, Pike JW, Adam JS (eds.). Vitamin D: Two-Volume Set. Academic Press. ISBN   978-0123819789.
  191. 1 2 3 Adams JS, Hewison M (February 2010). "Update in vitamin D". The Journal of Clinical Endocrinology and Metabolism. 95 (2): 471–8. doi:10.1210/jc.2009-1773. PMC   2840860 . PMID   20133466.
  192. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW (May 2004). "Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase". Proceedings of the National Academy of Sciences of the United States of America. 101 (20): 7711–5. Bibcode:2004PNAS..101.7711C. doi: 10.1073/pnas.0402490101 . PMC   419671 . PMID   15128933.
  193. Laing CJ, Cooke NE (2004). "Section I: Ch. 8: Vitamin D Binding Protein". In Feldman D, Glorieux FH, Pike JW (eds.). Vitamin D. Vol. 1 (2 ed.). Academic Press. pp. 117–134. ISBN   978-0-12-252687-9. Archived from the original on 19 March 2023. Retrieved 9 April 2017.
  194. Holick MF, Kleiner-Bossaller A, Schnoes HK, Kasten PM, Boyle IT, DeLuca HF (October 1973). "1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine". The Journal of Biological Chemistry. 248 (19): 6691–6. doi: 10.1016/S0021-9258(19)43408-X . PMID   4355503.
  195. Horst RL, Reinhardt TA, Ramberg CF, Koszewski NJ, Napoli JL (July 1986). "24-Hydroxylation of 1,25-dihydroxyergocalciferol. An unambiguous deactivation process". The Journal of Biological Chemistry. 261 (20): 9250–6. doi: 10.1016/S0021-9258(18)67647-1 . PMID   3013880.
  196. Doroudi M, Schwartz Z, Boyan BD (March 2015). "Membrane-mediated actions of 1,25-dihydroxy vitamin D3: a review of the roles of phospholipase A2 activating protein and Ca(2+)/calmodulin-dependent protein kinase II". The Journal of Steroid Biochemistry and Molecular Biology. 147: 81–84. doi:10.1016/j.jsbmb.2014.11.002. PMC   4323845 . PMID   25448737.
  197. Hii CS, Ferrante A (March 2016). "The Non-Genomic Actions of Vitamin D". Nutrients. 8 (3): 135. doi: 10.3390/nu8030135 . PMC   4808864 . PMID   26950144.
  198. 1 2 3 "Cod Liver Oil: History". Rosita. Retrieved 5 December 2024.
  199. 1 2 3 Hernigou P, Auregan JC, Dubory A (March 2019). "Vitamin D: part II; cod liver oil, ultraviolet radiation, and eradication of rickets". Int Orthop. 43 (3): 735–49. doi:10.1007/s00264-019-04288-z. PMID   30627846.
  200. Jones G (April 2022). "100 YEARS OF VITAMIN D: Historical aspects of vitamin D". Endocrine Connections. 11 (4). doi:10.1530/EC-21-0594. PMC   9066576 . PMID   35245207.
  201. Carere S (25 July 2007). "Age-old children's disease back in force". Toronto Star . Archived from the original on 17 May 2008. Retrieved 24 August 2010.
  202. McClean FC, Budy AM (28 January 1964). "Vitamin A, Vitamin D, Cartilage, Bones, and Teeth". Vitamins and Hormones. Vol. 21. Academic Press. pp. 51–52. ISBN   978-0-12-709821-0. Archived from the original on 19 March 2023. Retrieved 19 March 2023.
  203. "Adolf Windaus – Biography". Nobelprize.org. 25 March 2010. Archived from the original on 24 July 2018. Retrieved 25 March 2010.
  204. "History of Vitamin D". University of California at Riverside. 2011. Archived from the original on 16 October 2017. Retrieved 9 May 2014.
  205. Rosenheim O, King H (1932). "The Ring-system of sterols and bile acids. Part II". J. Chem. Technol. Biotechnol. 51 (47): 954–7. doi:10.1002/jctb.5000514702.
  206. Askew FA, Bourdillon RB, Bruce HM, Callow RK, St. L. Philpot J, Webster TA (1932). "Crystalline Vitamin D". Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character. 109 (764): 488–506. doi: 10.1098/rspb.1932.0008 . JSTOR   81571.
  207. Hirsch AL (2011). "Industrial aspects of vitamin D". In Feldman DJ, Pike JW, Adams JS (eds.). Vitamin D. Academic Press. p. 73. ISBN   978-0-12-387035-3. Archived from the original on 19 March 2023. Retrieved 19 March 2023.
  208. Haussler MR, Norman AW (January 1969). "Chromosomal receptor for a vitamin D metabolite". Proceedings of the National Academy of Sciences of the United States of America. 62 (1): 155–62. Bibcode:1969PNAS...62..155H. doi: 10.1073/pnas.62.1.155 . PMC   285968 . PMID   5253652.
  209. Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT, Anderson RR, et al. (October 1980). "Photosynthesis of previtamin D3 in human skin and the physiologic consequences". Science. 210 (4466): 203–5. Bibcode:1980Sci...210..203H. doi:10.1126/science.6251551. JSTOR   1685024. PMID   6251551.